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Abstract 
 
Leucyl-tRNA synthetase (LeuRS) plays dual roles within the yeast 
mitochondria. In addition to protein synthesis, it is also essential to RNA 
splicing of critical respiratory genes. The LeuRS collaborates with a 
maturase to excise the bI4 and aI4α introns from the cob and cox1α genes 
respectively. The LeuRS-based suppressor mutations have been isolated 
within the amino acid editing CP1 domain and restore native RNA splicing 
activity in the presence of an inactive maturase. Mutational analysis of 
these sites and the regions that surround them demonstrated that certain 
substitutions can also inactivate LeuRS-dependent splicing activity under 
in vivo and in vitro conditions. Binding measurements suggest that these 
suppressor sites are important in maintaining interaction between LeuRS 
and the group I intron RNA. Thus, CP1 domain binds specifically to the 
bI4 and aI4α intron to promote RNA splicing. 
 In addition to LeuRS from yeast mitochondria (ymLeuRS), diverse 
LeuRSs from varied origins such as M. tuberculosis and human 
mitochondria complement the ymLeuRS activities. Similarly, wild-type E. 
coli LeuRS (EcLeuRS) complemented a ymLeuRS null strain. Interestingly, 
at reduced levels of EcLeuRS expression in yeast mitochondria, the 
heterologous synthetase supported protein synthesis, but not intron splicing. 
Thus, it is a weak splicing suppressor. Surprisingly, a gain of splicing 
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activity was exhibited by positive charge substitutions at the Ala293 
position, suggesting that this Ala293 can be adapted for alternative 
activities. 
 Preliminary footprinting data suggest that LeuRS binds to the P4-P6 
core region of the bI4 intron that is cognate to LeuRS. The RNA duplex 
mimics of the P6 helix were designed and it was shown that LeuRS 
promotes their annealing in an ATP-independent manner. Domain analysis 
of LeuRS shows that the C-terminal domain is critical to the RNA 
annealing activity. Yeast mitochondrial tRNALeu (ymtRNALeu) 
competitively inhibit annealing. Also, an ymtRNALeu variable-stem-like 
region was identified on the P6 stem that is important for LeuRS-dependent 
annealing. These data support that the annealing and tRNA variable arm 
binding sites overlap on the C-terminal domain of LeuRS. It was shown 
that the overhang location and length of the duplexes are important features 
that LeuRS recognizes. It was hypothesized that LeuRS plays a key role in 
remodeling specific group I intron ribozymes so that they can productively 
self-splice. 
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Chapter 1. Introduction 
 1.1 Overview of aminoacyl-tRNA synthetases 
    Aminoacyl-tRNA synthetases (AARSs) are an ancient family of 
enzymes catalyzing the first step of protein synthesis (Ibba & Söll, 2000; 
Pang, Poruri, & Martinis, 2014; Ribas de Pouplana & Schimmel, 2001a). 
In prokaryotes, there are 20 AARSs for each of the 20 standard amino acids. 
In eukaryotes, there are two sets of AARSs encoded in the nuclear. One set 
is targeted to cytoplasm and the other to the mitochondria. In plants and 
some parasitic species, there is a third set of AARSs for chloroplast and 
apicoplasts, respectively (Brandao & Silva-Filho, 2011). Each of the amino 
acids corresponds to one or more cognate transfer RNAs (tRNAs) and is 
recognized as single AARS (except lysine which is recognized by two 
AARSs in some species (Leveque, Plateau, Dessen, & Blanquet, 1990). 
    The AARSs catalyze a reaction called aminoacylation, which 
covalently attaches amino acids to the cognate tRNA isoacceptors. In 
addition, during the lengthy evolutionary period of AARSs, they have 
acquired cellular activities other than aminoacylation and protein synthesis 
(M. Guo, Schimmel, & Yang, 2010; Martinis, Plateau, Cavarelli, & 
Florentz, 1999), such as mitochondrial RNA splicing (Lambowitz & 
Perlman, 1990), transcriptional regulation (Putney & Schimmel, 1981), 
translational regulation (Romby et al., 1996). They can impact 
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angiogenesis and the immune response as well as signaling pathways, such 
as those induced by mTOR (Bonfils et al., 2012; Han et al., 2012), IFN-γ 
(Wakasugi et al., 2002) and p53 (Sajish et al., 2012). 
1.1.1 Classification 
The AARSs are categorized into two classes based on sequence, 
structure and functional properties (Cusack, Berthet-Colominas, Hartlein, 
Nassar, & Leberman, 1990; Eriani, Delarue, Poch, Gangloff, & Moras, 
1990; Ribas de Pouplana & Schimmel, 2001b) (Table 1.1). The 
classification is consistent among all the living organisms except for LysRS, 
which is classified into Class I in euryarchaeal species while Class II in 
others (Ibba et al., 1997). Each class can be further divided into subclasses 
based on more extensive sequence homology, structural and mechanistic 
features (Cusack, 1995; Landes et al., 1995; Ribas de Pouplana & 
Schimmel, 2001b).  
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Table 1.1 Classification of AARSs based on 
         sequence and structural homology 
Class I Class II 
Ia IIa 
LeuRS* SerRS 
IleRS* ThrRS* 
ValRS* AlaRS* 
MetRS* GlyRS 
CysRS ProRS* 
ArgRS HisRS 
  
Ib IIb 
GlnRS AspRS 
GluRS AsnRS 
LysRS-I LysRS-II* 
  
Ic IIc 
TyrRS PheRS* 
TrpRS  
 SepRS 
 PylRS 
* The AARSs possess proofreading activities 
to clear misactivated and/or mischarged amino acids. 
 
    The Class I AARS catalytic core is characterized by a Rossmann ATP 
binding fold consisting of six parallel β-strands intervened by four α-
helices (Irwin, Nyborg, Reid, & Blow, 1976; Rould, Perona, Soll, & Steitz, 
1989). In the catalytic core there are two consensus sequences unique in 
Class I AARSs (Schimmel, 1987): “KMSKS” (Lys-Met-Ser-Lys-Ser) 
(Brick, Bhat, & Blow, 1989; Hountondji, Dessen, & Blanquet, 1986; Rould 
et al., 1989; Schmitt, Meinnel, Blanquet, & Mechulam, 1994) and “HIGH” 
(His-Ile-Gly-His) (Webster, Tsai, Kula, Mackie, & Schimmel, 1984). In the 
aminoacylation reaction, the “KMSKS” and “HIGH” loops move closer to 
the catalytic core and help stabilize the substrates, switching the catalytic 
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core from an “opened” to “closed” conformation (Ilyin et al., 2000; 
Nakama, Nureki, & Yokoyama, 2001). Distinct from the Class II AARSs 
introduced below, Class I AARSs bind to an ATP molecule in an extended 
conformation (Brick et al., 1989; Brick & Blow, 1987; Perona, Rould, & 
Steitz, 1993; Rould et al., 1989), interact with the minor groove of the 
tRNA accepter stem (Arnez & Steitz, 1996; Rould et al., 1989), and 
catalyze the addition of amino acid onto the 2’-OH of the terminal ribose 
on the tRNA (Perona et al., 1993; Sprinzl & Cramer, 1975). 
While the Class I AARSs are typically monomeric, Class II AARSs 
are dimeric or tetrameric. The aminoacylation core of Class II AARSs is 
composed of seven antiparallel β-strands surrounded by α-helices (Cusack 
et al., 1990; Eriani et al., 1990; Rossmann, Moras, & Olsen, 1974). Unlike 
the Rossmann ATP binding fold in Class I AARSs, this structure is not 
widely spread in protein structures. Class II AARSs are marked by three 
consensus motifs. Motif 1 is g𝜙xx𝜙xxp𝜙𝜙, motif 2 fRxe-h/rxxxFxxx(d/e), 
and motif 3 g𝜙g𝜙g𝜙(d/e)R𝜙𝜙𝜙𝜙 (x: variant; 𝜙: hydrophobic; lower case 
letter: amino acid partially conserved). Motif 1 is found at dimer interface, 
and is proposed to help with communication between the two active sites 
(Arnez et al., 1995). Motif 2 and motif 3 are part of the aminoacylation 
core (Cusack et al., 1990; Eriani et al., 1990; Ruff et al., 1991). Different 
from the Class I AARSs, Class II AARSs bind to a bent ATP molecule 
(Arnez & Moras, 1997; Cavarelli et al., 1994), bind the major groove of 
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the tRNA accepter stem (Ruff et al., 1991; Sankaranarayanan et al., 1999) 
and add the amino acid onto the 3’-OH of the terminal ribose on the tRNA 
(Cavarelli et al., 1994; Sprinzl & Cramer, 1975), with the exception of 
PheRS, which adds Phe to the 2’-OH of tRNAPhe (Goldgur et al., 1997). 
Apart from the AARSs named after the 20 standard amino acids, SepRS 
(O-phosphoserine-RS) and PyrRS (pyrrolysine-RS) have been discovered 
later and grouped into the Class II AARSs (O'Donoghue, Sethi, Woese, & 
Luthey-Schulten, 2005; Polycarpo et al., 2004). 
1.1.2 Mechanism of aminoacylation reaction 
The AARSs-catalyzed aminoacylation reaction can be further 
dissected into two steps (Figure 1.1): First, the amino acid is activated by 
ATP, forming aminoacyl-adenylate intermediate (AA-AMP). Although 
tRNA is not a substrate in the first step, the cognate tRNAs have been 
reported to function as cofactors for GluRS, GlnRS, ArgRS and LysRS-I. 
Second, the amino acid is transferred to the 3ʹ-end of the tRNA bound by 
the AARS, forming aminoacylated tRNA (AA-tRNAAA) (A. P. 
Mascarenhas, An, Rosen, Martinis, & Musier-Forsyth, 2009; Pang et al., 
2014). Then the aminoacyl tRNA is transported to the ribosome by EF-Tu 
and the aminoacyl group be added to the growing polypeptide chain, 
directed by the codons in a messenger RNA. 
6 
 
 
Figure 1.1 Two-step aminoacylation reaction catalyzed by AARSs. 
Step 1 is ATP-dependent activation of the amino acid (AA), forming the 
enzyme-bound aminoacyl adenylate (AA-AMP) intermediate at the 
synthetic active site. The first step involves a nucleophilic attack by the α-
carboxyl oxygen of the amino acid at the α-phosphate of ATP. Step 2 is the 
transfer of the activated amino acid to the 3ʹ-end of the tRNA. In the second 
step the 2ʹ-OH of the ribose ring of terminal adenosine at the 3ʹ-end of 
tRNA makes a second nucleophilic attack (for class I AARSs) at the 
carboxyl carbon of the aminoacyl adenylate intermediate, forming the 
aminoacylated tRNA. 
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1.1.3 Proofreading (Editing) pathways in AARSs 
Faithful translation of genetic information from mRNAs to proteins is 
crucial for cells. Errors in translation can lead to accumulation of misfolded 
proteins which do not function properly, causing cell death in microbes 
and/or diseases for mammals. In the translation process, “check points” for 
the translational errors exist at several levels, including AARSs which 
catalyze charging of tRNAs with amino acids (A. P. Mascarenhas et al., 
2009), EF-Tu which transports the charged tRNAs to ribosomes (LaRiviere, 
Wolfson, & Uhlenbeck, 2001), ribosomes where amino acids on the tRNAs 
are translocated to the elongating polypeptide (Ogle, Murphy, Tarry, & 
Ramakrishnan, 2002; Zaher & Green, 2009). Among them, AARSs are the 
first check point, thus play a very important role in maintaining translation 
fidelity. 
    Editing function has been found in almost half of the AARSs (A. P. 
Mascarenhas et al., 2009). The strategies AARSs use to carry out editing 
include post-transfer editing and pre-transfer editing (Figure 1.2) (Sarkar 
& Martinis, 2011; Williams & Martinis, 2006). Post-transfer editing is 
hydrolysis of the mischarged tRNA. The post-transfer editing sites are 
usually not located in the aminoacylation catalytic core, but in a separate 
editing domain. The 3’-end of tRNA is translocated from the synthetic core 
to the editing domain, positioning the noncogate aminoacyl linkage for 
hydrolysis, followed by release of the tRNA and amino acid. 
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Figure 1.2 Scheme showing pre- and post-transfer editing pathways. 
The aminoacyl adenylate (AA-AMP) is the substrate for pre-transfer 
editing, while the mischarged tRNA (AA-tRNA) is the substrate for post-
transfer editing. 
 
Pre-transfer editing targets the misactivated aminoacyl-AMP (AA-
AMP) for hydrolysis to form AMP and free amino acid (Baldwin & Berg, 
1966). The enzyme either catalyzes the AA-AMP cleavage (selective 
hydrolysis) or release the AA-AMP into the solution for hydrolysis 
(selective release). Misactivated AA-AMP can be selectively hydrolyzed 
in a tRNA-independent or -dependent fashion (Minajigi & Francklyn, 2010; 
Splan, Ignatov, & Musier-Forsyth, 2008). This can occur either in the 
aminoacylation catalytic core (Gruic-Sovulj, Rokov-Plavec, & Weygand-
Durasevic, 2007) or following transfer to the editing domain that is 
originally proposed for post-transfer editing (M. T. Boniecki, Vu, Betha, & 
Martinis, 2008; Fukunaga & Yokoyama, 2006; Nomanbhoy, Hendrickson, 
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& Schimmel, 1999). 
Pre- and post-transfer editing can co-exist in one AARS (M. T. 
Boniecki et al., 2008; Martinis & Boniecki, 2010; Williams & Martinis, 
2006). For example, ProRS clears misactivated alanine by both pre-transfer 
(Beuning & Musier-Forsyth, 2000) and post-transfer editing (Wong, 
Beuning, Nagan, Shiba, & Musier-Forsyth, 2002) in some bacteria species. 
The dominance or partitioning of the two strategies in one AARS has been 
found to be directed by the availability of the active sites and the types of 
noncognate amino acids (M. T. Boniecki et al., 2008; Martinis & Boniecki, 
2010; Sarkar & Martinis, 2011). For example, the pre-transfer editing 
activity of E. coli LeuRS is unmasked when certain post-transfer editing 
active site residues are mutated or the whole editing domain deleted (X. 
Chen et al., 2011; Williams & Martinis, 2006). Human cytoplasmic LeuRS 
clears misactivated amino acid-like synthetic intermediates, α-
aminobutyrate and novaline, by pre- and post-transfer editing respectively 
(X. Chen et al., 2011). The balance between pre-transfer and post-transfer 
editing redundantly ensures the highest-possible translation fidelity for 
AARSs. 
Paradoxily, there are AARSs that are naturally editing-deficient, 
which contributes to produce a proteome with more statistical mutations. 
Examples include the parasite Mycoplasma mobile LeuRS which lacks the 
editing domain in LeuRS (L. Li et al., 2011). The error-prone proteome 
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should be beneficial for those living organisms in certain environments. 
1.1.4 Overview of alternative cellular functions in AARSs 
As one of the most ancient protein families, AARSs have acquired a 
repertoire of non-translational functions that are crucial for cell metabolism 
during their lengthy evolution (Figure 1.3) (Martinis et al., 1999; Pang et 
al., 2014). These functions have been found in both lower and higher 
organisms. Some of the discovered secondary functions capitalize upon 
nucleic acid binding capability of AARSs. For example, when E. coli 
tRNATyr concentration is low, excess tyrosyl-tRNA synthetase binds to a 
tRNATyr-like sequence upstream of its translation start site and prevents its 
own translation. The E. coli AlaRS binds to a palindromic sequence in the 
promoter region of its gene and represses its own transcription (Putney & 
Schimmel, 1981). In lower eukaryotes, mitochondrial LeuRS in 
Saccharomyces cerevisiae and TyrRS in Neurospora crassa bind to certain 
group I introns to act as splicing factors in processing the pre-mRNAs 
(Lambowitz & Perlman, 1990). 
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Figure 1.3 Non-canonical functions of AARSs. AARSs adapted to 
encompass secondary roles in addition to their aminoacylation function. 
 
The amino-acid binding capability of AARSs link them to some 
signaling pathways that have amino acids and/or their metabolites 
identified as centrals of the pathways. For instance, human and S. 
cerevisiae cytoplasmic LeuRSs serve as intracellular leucine sensors and 
signals to TORC1 in the TOR pathway, which is a pathway that regulates 
nutrition intake and cell growth (Bonfils et al., 2012; Han et al., 2012). 
Instead of using the tRNA and amino-acid binding sites, some higher 
eukaryotes have evolved appended domains that specialize in non-
translational functions of AARSs (M. Guo et al., 2010). Interestingly, these 
appended domains usually emerge at important transition points in 
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evolution. The number and complexity of these appended domains in 
AARSs correlate with the complexity of the organism on the tree of 
evolution. This is not observed in other ancient protein families, such as 
ribosomal proteins. Many of these appended domains are dispensable for 
aminoacylation and are specifically evolved for protein-protein 
interactions. 
For example, the WHEP domain of tryptophanyl-tRNA synthetase 
(TrpRS) emerges in insects and then mere maintained thereafter. The name 
of WHEP domain comes from 3 of the 5 WHEP containing AARSs: TrpRS 
(W), HisRS (H) and GluProRS (EP). Deleting the WHEP domain has 
negligible effects on aminoacylation activity of TrpRS. However, it has 
been shown that there is a strong correlation between human TrpRS level 
in nucleus and the mechanics of IFN-γ-induced antiproliferation. In 
particular, the WHEP domain plays a key role by co-localizing DNA-
dependent protein kinase (DNA-PKcs) and poly (ADP-ribose) polymerase 
1 (PARP-1) to activate p53 (Wakasugi et al., 2002). 
Another example is the UNE-S domain in seryl-tRNA synthetase 
(SerRS). This 45-residue domain emerges in zebrafish (Xu et al., 2012), 
which is the transition point in evolution where the open circulation of 
invertebrates transforms to the closed circulation of vertebrates. It has been 
found that the UNE-S domain is dispensable for aminoacylation but 
required for vascular development in zebrafish embryo. 
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The secondary functions of some tRNA synthetases are revealed after 
being naturally fragmented by alternative splicing or proteolysis. For 
example, proteolysis specifically cleaves TyrRS in half. Both fragments 
then act as distinct cytokines in inflammatory pathways. The full-length 
TyrRS lacks of this activity (Wakasugi & Schimmel, 1999). Another 
example is the splice-variant of TrpRS that is missing the WHEP domain 
has been shown to have angiostatic effects. This activity is absent in the 
full-length TrpRS (Zhou et al., 2010). 
Mutations of tRNA synthetases correlate to many diseases. For 
example, mutations of different mitochondrial tRNA synthetases 
(mtAARSs) cause damage to very specific central neural cell types. Each 
leads to distinct clinical phenotypes (Konovalova & Tyynismaa, 2013). 
This suggests that each of these mtAARSs harbor important and different 
nontranslational functions in the neural system. Mutations of GlyRS and 
TyrRS, LysRS and AlaRS have been causally associated with Charcot-
Marie-Tooth (CMT) disease, which is an inheritable disease on the 
peripheral nerve system (Antonellis & Green, 2008; Zhao et al., 2012). 
1.2 Structure overview of leucyl-tRNA synthetase 
Several structures of LeuRS have been solved from different species, 
with different substrates bound, in both aminoacylation and editing 
conformations (Table 1.2). The architectural characteristics of LeuRS 
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structure is consistent with other Class I AARSs, of which the main body 
consists of Rossmann-fold catalytic domain with catalytically important 
“KMSKS” and “HIGH” conserved sequences, and the Class Ia anticodon–
binding domain. The LeuRS also has flexible inserted domains, including 
the zinc-binding domain, the connective polypeptide 1 (CP1) editing 
domain, the leucine-specific domain and the C-terminal domain (Figure 
1.4). Aminoacylation and editing of LeuRS in all species as well as the 
group I intron splicing function in S. cerevisiae mitochondria LeuRS, 
involve coordination of the four flexible domains. 
    The aminoacylation catalytic core of LeuRS is composed of 
Rossmann adenylate binding fold. Upstream of the Rossmann fold (N-
terminal side in sequence) are two inserted zinc binding domains ZBD-1 
and ZBD-2. On the C-terminal side of the Rossmann fold is the anticodon 
binding domain characterized by five α-helices structure seen in Class Ia 
AARS structures. Further downstream is the C-terminal domain that binds 
the corner of tRNALeu. 
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Table 1.2 Compilation of solved crystal structures of LeuRS 
PDB ID Reference Structure description 
1H3N (Cusack, Yaremchuk, & Tukalo, 
2000) 
T. Thermophilus LeuRS 
complexed with sulfamoyl 
ananlog of leucyl-adenylate 
1OBH (Lincecum et al., 2003) T. Thermophilus LeuRS 
complexed with a pre-transfer 
editing substrate analogue in 
both synthetic active site and 
editing site 
2BTE, 
2BYT 
(Tukalo, Yaremchuk, Fukunaga, 
Yokoyama, & Cusack, 2005) 
T. Thermophilus LeuRS 
complexed with a tRNALeu 
transcript in the post-editing 
conformation and a post-transfer 
editing substrate analogue 
1WZ2 (Fukunaga & Yokoyama, 2005) P. horikoshii LeuRS complexed 
with a tRNALeu transcript in the 
aminoacylation conformation 
2V0C, 
2V0G 
(Rock et al., 2007) T. Thermophilus LeuRS 
complexed with a sulfamoyl 
analogue of leucyl-adenylate in 
the synthetic site and an adduct 
of AMP with 5-fluoro-1,3-
dihydro-1-hydroxy-2,1-
benzoxaborole (AN2690) in the 
editing site 
2WFE (Seiradake et al., 2009) C. Albicans cytosolic LeuRS 
CP1 editing domain 
2WFG (Seiradake et al., 2009) C. Albicans cytosolic LeuRS 
CP1 editing domain bound to a 
benzoxaborole-AMP adduct 
2WFD (Seiradake et al., 2009) Human cytosolic LeuRS CP1 
editing domain 
4ARC (Palencia et al., 2012) E. coli LeuRS complexed with 
L-leucine in the post-editing 
conformation 
4ARI, 
4AS1 
(Palencia et al., 2012) E. coli LeuRS complexed with 
benzoxaborole 
4AQ7 (Palencia et al., 2012) E. coli LeuRS complexed with 
tRNALeu and Leu-AMS in the 
aminoacylation conformation 
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Figure 1.4 Crystal structure of E. coli LeuRS complexed with tRNALeu 
and Leu-AMS in the aminoacylation conformation. The overall 
structure is organized into discrete functional domains highlighted with 
different colors: catalytic domain, cyan; anticodon-binding domain, yellow; 
C-terminal binding domain, pink; CP1 domain, green; ZBD-1, orange 
(ZBD-2 not shown); and leucine-specific domain, black (PDB ID: 4AQ7) 
(Palencia et al., 2012). The tRNALeu is drawn as a brown tube. Conserved 
sequences HMGH and KMSKS are highlighted in purple and red, 
respectively. 
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1.2.1 The CP1 domain of LeuRS 
In the Rossmann fold of LeuRS, there is an inserted large domain 
(~200 amino acids) called connective polypeptide 1 domain (CP1 domain) 
(Cusack et al., 2000; Hou, Shiba, Mottes, & Schimmel, 1991; Starzyk, 
Webster, & Schimmel, 1987). The CP1 domain exists in all of the Class I 
AARSs. However, only in LeuRS, IleRS and ValRS are the CP1 domains 
functionally enlarged. The CP1 domain structure is conserved among 
LeuRS, IleRS and ValRS. The core of the CP1 domain comprises of seven 
β-strands and four α-helices. Two flanking β-strands connect the core to 
the main body of LeuRS. 
The insertion site of the CP1 domain varies in different AARSs of 
different species. The archaeal and eukaryotic cytosolic LeuRS as well as 
all ValRS and IleRS have the CP1 domain inserted between the two halves 
of the ZBD1 domain, whereas the bacteria and mitochondrial LeuRS have 
the CP1 domain after the ZBD1 domain. Interestingly, the CP1 domain of 
archaeal and eukaryotic LeuRS has the same orientation as the bacteria 
LeuRS, while ~180° rotated in ValRS and IleRS (Fukunaga & Yokoyama, 
2005). 
The CP1 domain is primarily responsible for the editing function 
(Mursinna, Lee, Briggs, & Martinis, 2004), as well as required for tRNA 
specific binding in the aminoacylation conformation (Fukai et al., 2000; 
Palencia et al., 2012; Silvian, Wang, & Steitz, 1999). A threonine rich 
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region within the CP1 domain of E. coli LeuRS was shown to be important 
for amino acid editing in vitro. T252Y mutation in this region blocks amino 
acid binding in the active site and abolishes editing activity (Mursinna & 
Martinis, 2002; Williams & Martinis, 2006). However, a secondary site 
mutation A293D on the CP1 domain activated a pre-transfer editing 
pathway when the post-transfer editing pathway is inhibited by T252Y 
mutation (Williams & Martinis, 2006). Apart from amino acid editing, the 
ymLeuRS CP1 fragment has been shown to facilitate splicing of group I 
intron in the cytochrome b open reading frame in vitro (Sarkar, Poruri, 
Boniecki, McTavish, & Martinis, 2012). 
1.2.2 The C-terminal domain of LeuRS 
The C-terminal domain of LeuRS in E. coli LeuRS interacts with the 
D-loop, T-loop and the variable arm of the tRNALeu in aminoacylation and 
editing, whereas for other Class I AARSs except LeuRS, the C-terminal 
domain interacts with the tRNA anticodon region and contributes to the 
tRNA discrimination. In the transition from aminoacylation to editing 
conformation, the C-terminal domain moves synchronously with the 
tRNALeu to maintain the interaction with the variable arm and T-loop of 
tRNALeu (Palencia et al., 2012). 
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1.3 LeuRS recognition of tRNA 
In general, tRNAs have similar secondary and tertiary structures 
(Figure 1.5). AARSs recognize their respective tRNAs by sequence and 
structural features on the tRNAs called identity elements, which typically 
include the discriminator base N73, sequences on the acceptor stem and 
the anticodon (Giege, Sissler, & Florentz, 1998; Soma, Kumagai, 
Nishikawa, & Himeno, 1996). For some AARSs, the variable loop and the 
D arm also contribute to tRNA recognition. Although there are general 
rules for tRNA recognition, the identity elements vary among different 
AARS-tRNA pairs in different species. 
 
Figure 1.5 Conserved structure of tRNA. The E. coli tRNALeuCAA is 
shown as an example. On the left is the tRNA secondary structure. The 
“CAA” anticodon is colored in red. On the right is the tRNA tertiary 
structure. The stem-loops are highlighted with different colors: acceptor 
stem, orange; DHU loop, red; anticodon stem, blue; anticodon loop, grey; 
variable loop, yellow; TΨC stem, green. 
20 
 
Unlike most AARSs, LeuRS, AlaRS (Francklyn & Schimmel, 1989) 
and SerRS (Biou, Yaremchuk, Tukalo, & Cusack, 1994; Borel, Vincent, 
Leberman, & Hartlein, 1994) do not use the anticodon loop of their tRNAs 
as a recognition element as there is too much variation in the anticodons of 
these isoaccpeters (Asahara et al., 1993; Breitschopf, Achsel, Busch, & 
Gross, 1995; Larkin, Williams, Martinis, & Fox, 2002). For example, 
LeuRS recognizes six tRNALeu isoaccepters, each with a different 
anticodon. The known exception is S. cerevisiae cytoplasmic LeuRS, of 
which efficient leucylation is dependent on specific sequences of the 
anticodon loop (Soma et al., 1996). The identity elements in 
LeuRS:tRNALeu recognition generally include the discriminator base N73 
at the end of the acceptor stem. Specifically, for E. coli LeuRS, the identity 
elements also include a unique structural motif contributed by the triple 
interaction that is formed between A15:U48 and A20a at the D- and T-arms 
of tRNA, as well as the invariant G18G19. For archaeal (Fukunaga & 
Yokoyama, 2005) and human cytoplasmic LeuRS (Breitschopf et al., 1995) 
but not S. cerevisiae cytoplasmic (Soma et al., 1996) or E.coli LeuRS 
(Asahara et al., 1993), the long variable arm of tRNALeu is an important 
recognition element. 
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1.4 Protein-facilitated group I intron splicing 
1.4.1 Mechanisms and structures of group I intron splicing 
Splicing is a modification of nascent precursor RNAs in which introns 
removed and exons ligated. Splicing pathways can be categorized into four 
types with distinct mechanisms: group I and group II intron self-splicing, 
spliceosomal splicing and tRNA splicing (Irimia & Roy, 2014). The focus 
here is the group I intron splicing. 
Group I introns have been found mostly in organelle genomes as well 
as some nucleic, bacterial and bacterial-phage genes. In group I intron 
splicing, the folded RNA structure participate directly in the splicing 
reaction. Some of them undergo self-splicing in the absence of proteins in 
vitro, while others require proteins to facilitate their splicing but still use 
the RNA as catalytic center (Burke, 1988; Lambowitz & Perlman, 1990). 
    Self-splicing of group I intron proceeds via two consecutive 
transesterification reactions (Cech, 1990). First, an exogenous guanosine 
or one of its phosphorylated forms (GMP, GDP, GTP) binds to a certain 
guanosine-binding site on the 3  ´ region of the intron. The 3 -´OH of the 
guanosine attacks the phosphorus group on the 5  ´splice site, forming a 3 ,´ 
5 -´phosphodiester bond with the first nucleotide of the intron, resulting in 
excision of the upstream exon (Cech, 1987; Zaug, Grabowski, & Cech, 
1983). Then the hydroxyl group on the upstream exon attacks the 
22 
 
phosphorus group on the 3’ splice site, yielding ligated exons and deleted 
intron. 
The group I introns share a conserved secondary structure, made up 
of a series of base-paired regions (P1-P10) interrupted by extra unpaired 
sequences (Figure 1.6). The P1 and P10 regions contain the 5ʹ- and 3ʹ-
splice site, respectively and are formed by base pairing between an internal 
guide sequence (IGS) (generally located downstream of the 5ʹ-splice site) 
(Davies, Waring, Ray, Brown, & Scazzocchio, 1982) and the exon 
sequences flanking the splice sites (Figure 1.6). The P1 regions of different 
group I introns vary in sequence, with only one conserved base pair 
between the U immediately preceding the 5ʹ-splice site and a G in the IGS 
(Cech, 1990). 
23 
 
 
Figure 1.6 Conserved secondary structure of group I intron. The 3 -´ 
and 5 -´flanking exon sequences are shown in green. Dashes indicate base 
pairs and dots indicate wobble base pairs. Dashed red lines indicate 
continuity of intron strand. Tertiary interactions have been omitted for 
clarity. The conserved U•G base pair in the internal guide sequence (IGS), 
near the 5 -´splice site is highlighted in blue. The guanosine binding site is 
denoted by asterisk (*). The figure is adapted from (Cech, et al., 1994). 
 
The three-dimensional splicing-competent structure of the group I 
intron is also conserved, with the catalytic core consisting of two extended 
RNA domains: P4-P6 and P3-P9. The two domains interact to form the 
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splicing active site. Folding of the intron into this competent structure 
brings the guanosine-binding site and the splice sites in close proximity, 
which are originally at distance in primary structure, so that the two 
transesterification reactions can take place (Cech, 1988). 
1.4.2 Protein facilitation of group I intron splicing 
Group I intron splicing is facilitated by protein splicing factors in vivo 
(Burke, 1988; Lambowitz, Caprara, Zimmerly, & Perlman, 1999; 
Lambowitz & Perlman, 1990). Most of the splicing factors identified so far 
are proposed to facilitate folding of the intron into the correct catalytic 
active conformation (Burke, 1988; Cech, 1988, 1990; Tinoco & 
Bustamante, 1999). One group of the group I intron splicing factors are 
intron-encoded maturases, which typically only facilitate splicing of their 
encoding introns (Lazowska, Jacq, & Slonimski, 1980). One exception is 
the cob-I4 (bI4) maturase in yeast mitochondria, which not only aids bI4 
intron splicing but also cox1α-I4 (aI4α) splicing (De La Salle, Jacq, & 
Slonimski, 1982; Dhawale, Hanson, Alexander, Perlman, & Mahler, 1981). 
The nuclear-encoded protein splicing factors of group I introns 
include LeuRS (or NAM2) (Herbert, Labouesse, Dujardin, & Slonimski, 
1988; Labouesse, 1990) and Mss116p in S. cerevisiae mitochondria, TyrRS 
or (CYT-18) and CTY-19 in N. crasssa mitocohondria. The yeast 
mitochondrial LeuRS (ymLeuRS) is required for splicing of bI4 and aI4α 
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introns (Herbert et al., 1988), while CYT-18 essential for splicing of large 
rRNA intron as well as intron in the cob and ATPase 6 genes (Akins & 
Lambowitz, 1987; Cherniack, Garriga, Kittle, Akins, & Lambowitz, 1990; 
Majumder et al., 1989). Other than that, CYT-18 can facilitate splicing of 
a variety of completely irrelevant group I introns, whereas splicing activity 
of ymLeuRS has not been identified in other RNAs except the two group I 
introns described above. 
Biochemical and footprinting data indicates that CYT-18 promote 
splicing of group I introns in a two-step sequential manner: it first binds to 
the P4-P6 region, which serves as a scaffold on which the P3-P9 region 
assembles (Caprara, Mohr, & Lambowitz, 1996). The solved structure of 
N. crasssa mitocohondria TyrRS bound to a group I intron shows the intron 
binds across the two subunits of the homodimeric CYT-18 (Figure 1.7) 
(Paukstelis, Chen, Chase, Lambowitz, & Golden, 2008). Instead of using 
the tRNATyr binding sites, TyrRS evolves distinct RNA-binding surface for 
the intron. It is proposed that TyrRS acts as an extended scaffold to stabilize 
the conserved catalytic core of the intron, which explains why it can 
promote splicing of completely irrelevant group I introns. 
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Figure 1.7 Structure of N. crassa TyrRS bound to a group I intron RNA. 
The P4-P6 and the P3-P9 domains of the intron are highlighted in red and 
green respectively (PDB ID: 2KJ) (Paukstelis et al., 2008). 
 
CYT-19 and Mss116p, from N. crassa and S. cerevisiae, respectively, 
stimulate splicing of a variety of group I and II introns, which indicates that 
they recognize general structural features instead of a specific feature of a 
single RNA (Halls et al., 2007; S. Mohr, Matsuura, Perlman, & Lambowitz, 
2006; S. Mohr, Stryker, & Lambowitz, 2002; Solem, Zingler, & Pyle, 2006; 
Tijerina, Bhaskaran, & Russell, 2006). CYT-19 has also been shown to 
work in concert with CYT-18 in splicing of the N. crassa mt LSU and 
Tetrahymena AP5abc group I introns in vitro (S. Mohr et al., 2002). 
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1.4.3 Role of LeuRS in group I intron splicing 
The ymLeuRS encoded by the nuclear gene and transported into 
mitochondria was first implicated to play a role in splicing by its capability 
to suppress a splicing-deficient bI4 intron maturase mutation (Labouesse, 
Herbert, Dujardin, & Slonimski, 1987). Both ymLeuRS and bI4 maturase 
are required for splicing of the bI4 and aI4α introns. It was found that the 
two proteins bind independently to the bI4 intron and stimulate splicing 
(Figure 1.8) (Rho & Martinis, 2000). 
 
Figure 1.8 Schematic representation of LeuRS-assisted splicing. The 
yeast mitochondrial LeuRS (ymLeuRS) facilitates splicing of two related 
group I introns, bI4 and aI4α from the yeast mitochondrial cob and cox1α 
genes, respectively. The bI4 maturase (encoded by the ORF of intron bI4) 
and nuclear-encoded ymLeuRS act in collaboration to aid in splicing of 
these two introns. (Color legend: group I intron, blue; group II intron, 
yellow; exon, red; intron ORFs, white). 
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Molecular determinants have been identified in LeuRS, although the 
mechanism of splicing stimulation by LeuRS is still unknown. The CP1 
domain of LeuRS is able to suppress the splicing deficiency just like the 
full-length LeuRS, in which the two β-strands that link the CP1 domain to 
the main body are essential (Rho, Lincecum, & Martinis, 2002). The N-
terminal linking β-strand contains a conserved WIG sequence, in which 
W273 and G240 identified to be splicing sensitive sites by mutagenesis in 
the splicing-deficiency suppression experiments (Labouesse, 1990; 
Labouesse, Dujardin, & Slonimski, 1985; G. Y. Li, Becam, Slonimski, & 
Herbert, 1996). The role of CP1 domain in splicing has been further 
confirmed in vitro (Sarkar et al., 2012). Apart from the CP1 domain, the C-
terminal domain of LeuRS was also involved in splicing and functionally 
diverged to accommodate both splicing and aminoacylation (Hsu, Rho, 
Vannella, & Martinis, 2006). 
1.4.4 RNA remodeling proteins 
Most RNAs must adopt certain competent tertiary structures to be 
biologically active, such as tRNAs, group I and II self-splicing introns, 
small ribozymes, long non-coding RNAs and some local untranslated 
regions on mRNAs. Folding into the correct structures is critical for RNAs 
to be recognized by their protein partners in ribonucleoproteins (RNPs) and 
for the RNA ribozymes to be catalytic active (Batey, 2006). 
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The structured RNA usually include short A-form helices (typically 
<10 base pairs) as elements of secondary structure that interact with each 
other to form the overall three-dimensional structure. RNA folding is 
usually described as a hierarchical process, meaning that the elements of 
secondary structure are largely stable in the absence of tertiary structure, 
unchanged when tertiary structures formed, and unaffected when the 
tertiary structures disturbed (Tinoco & Bustamante, 1999). 
In the folding process, there are two problems RNAs can face and 
RNA remodeling proteins can help with: a thermodynamic one and a 
kinetic one (Davila-Aponte, Huss, Sogin, & Cech, 1991; Jaeger, Westhof, 
& Michel, 1991; Michel et al., 1992; Riesner et al., 1979; Szostak & Sekula, 
1991; Tanner & Cech, 1985; Walstrum & Uhlenbeck, 1990; Weeks, 1997). 
The thermodynamic problem is that an RNA has difficulty in specifying 
the native structure from other similarly stable competing structures. The 
kinetic problem is that numerous stable misfolded conformations that an 
RNA can adopt cause the folding process difficult to accomplish on a time-
scale (Russell & Herschlag, 2001). 
    RNA remodeling proteins can be categorized into RNA chaperones 
including RNA helicases, RNA annealers and specific RNA binding 
proteins (Table 1.3) (Rajkowitsch et al., 2007). They are reviewed briefly 
below. 
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Table 1.3 Definition of terms related to protein-assisted RNA 
remodeling 
RNA chaperone (protein with RNA chaperone activity) 
A protein that binds non-specifically and transiently to RNA and resolves kinetically 
trapped, misfolded conformations. RNA chaperone activity entails the disruption of 
RNA-RNA interactions and the loosening of RNA structures. The interaction with 
the protein is needed for the unfolding of the RNA but to maintain its structure. The 
protein does not require ATP-binding or hydrolysis for its activity. Examples: StpA 
(Müller, Lambert, & Göringer, 2001; O. Mayer, Rajkowitsch, Lorenz, Konrat, & 
Schroeder, 2007), L1 (Semrad, Green, & Schroeder, 2004), S1 (Bear et al., 1976; O. 
Mayer et al., 2007; Subramanian, 1983), S12 (Coetzee, Herschlag, & Belfort, 1994) 
RNA annealer (protein with RNA annealing activity) 
A protein that accelerates annealing of complementary RNAs. It can act by binding 
to one or both RNAs thereby enhancing the local concentration and the probability 
of RNA-RNA interactions (molecular crowding, Example: Hfq (Rajkowitsch & 
Schroeder, 2007b)). A protein with matchmaker activity also alters the structure of 
the RNA upon binding, thereby rendering it annealing-competent (Example: gBP21 
(Muller & Goringer, 2002)). 
RNA helicase 
A member of the DExD/H-box protein family that utilizes energy derived from ATP 
hydrolysis to resolve RNA structures and to displace RNA-bound proteins. Only few 
are processive, whereas most of the well characterized RNA helicases are non-
processive “unwindases” such as DED1, elF4A, CYT-19 and Mss116p (Jankowsky 
& Fairman, 2007). 
Specific RNA-binding protein 
A protein ligand (protein cofactor) that binds specifically to an RNA and thereby 
contributes to its native folding and thermodynamic stability. The continuous 
interaction with the protein is required to maintain the functional RNA structure. 
Examples: CYT-18 (G. Mohr, Zhang, Gianelos, Belfort, & Lambowitz, 1992; 
Waldsich, Grossberger, & Schroeder, 2002), CBP2 (Bokinsky et al., 2006; Gampel, 
Nishikimi, & Tzagoloff, 1989), LtrA (Singh, Saldanha, D'Souza, & Lambowitz, 
2002). 
1.4.4.1 RNA chaperones 
RNA chaperones can help solve the kinetic folding problem by 
preventing misfolding or by resolving misfolded structures (Clodi, Semrad, 
& Schroeder, 1999; Herschlag, 1995; Herschlag, Khosla, Tsuchihashi, & 
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Karpel, 1994; Munroe & Dong, 1992; Phadtare, Inouye, & Severinov, 2002; 
Schroeder, Barta, & Semrad, 2004; Waldsich et al., 2002). RNA 
chaperones come from a variety of established protein families that have 
been assigned with distinct functions, such as regulation of transcription, 
RNP assembly and stabilization, RNA export, virus replication and 
histone-like nucleoid structuring. Many of these protein families do not 
share any common sequence, fold or motif, thus employing different 
mechanisms when acting as RNA chaperones. 
The mechanism of RNA chaperones can be generally categorized into 
two groups: transient binding and ATP-dependent unwinding. The first 
group of RNA chaperones bind RNAs weakly and are not required to 
maintain the native structure after the folding process finished, suggesting 
that they only act on the RNAs transiently (R. J. Mayer, 1995). Due to their 
weak and non-specific binding, this group of RNA chaperones usually need 
to be in excess compared with the RNAs in the in vitro folding assays. 
However, when the protein:RNA ratio exceeds an optimal value, RNA 
folding is inhibited, probably because protein binding impairs RNA 
interactions (Cristofari & Darlix, 2002; R. J. Mayer, 1995). Many 
ribosomal proteins fall into this group of RNA chaperones. Among them, 
a small subunit protein S12 is one of the most effective one both in vitro 
(Coetzee et al., 1994) and in vivo (Coetzee et al., 1994). 
The second group of RNA chaperones are also called RNA helicases. 
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In contrast to the first group of RNA chaperones, RNA helicases are RNA-
dependent ATPases that require external energy input to unwind double-
stranded RNAs (Henn et al., 2010). They are highly similar to DNA 
helicases, and most of them belong to the DExD/H-box protein family 
(Jarmoskaite & Russell, 2014). 
Examples of RNA helicases include Mss116p and CYT-19, which 
stimulate intron splicing in an ATP-dependent manner in vitro (Halls et al., 
2007). The Mss116p splicing factor also shows RNA annealing activity, 
like many other DExD/H-box proteins. The annealing activity seems 
orthogonal to the unwinding activity, for it is ATP-independent and 
involves a different domain (Halls et al., 2007; Solem et al., 2006; Yang & 
Jankowsky, 2005). 
1.4.4.2 RNA annealers 
    Complementary RNA oligos can anneal on their own, but this process 
can be accelerated by RNA annealers up to the diffusion limit (Croitoru et 
al., 2006; Yang & Jankowsky, 2005). Molecular crowding might be one of 
the mechanisms RNA annealers employ, which results in increase of local 
oligo concentration and therefore enhances the possibility of annealing. 
This can be achieved by simultaneous binding to both of the oligos (R. J. 
Mayer, 1995; Rajkowitsch & Schroeder, 2007b). Longer RNAs can form 
stable local mismatched structures, which needs to be broken before 
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hybridization with the correct complementary sequence (Patzel & Sczakiel, 
1999). RNA annealers with matchmaker activity bind and disrupt the 
incorrect base-pairing and thereby exposing the RNA sequences to the 
correct intermolecular interactions (Muller, Lambert, & Goringer, 2001). 
Similarly, an RNA chaperone can release an RNA sequence from its 
kinetic trap before the annealing event (You & McHenry, 1994). 
Nevertheless, RNA annealers differ with RNA chaperones in the 
mechanism: instead of transient binding, RNA annealers continuously bind 
to the RNAs until annealing has been accomplished. However, it is usually 
difficult to distinguish them experimentally (Herschlag, 1995; Muller & 
Goringer, 2002; Rajkowitsch & Schroeder, 2007a, 2007b). 
One of the most thoroughly-studied RNA annealers is the E. coli host 
factor I/Q (Hfq). Electron microscopic and crystalized structures show that 
Hfq has a haxameric-ring structure and belongs to the large conserved Sm- 
or Sm-like proteins (Moller et al., 2002; Schumacher, Pearson, Moller, 
Valentin-Hansen, & Brennan, 2002; Zhang, Wassarman, Ortega, Steven, & 
Storz, 2002). Most data on Hfq-RNA interaction come from studies on 
small non-coding RNAs (ncRNAs) interacting with their target mRNAs. 
The Hfq protein facilitates in vitro annealing of spot42 RNA with galK 
mRNA (Moller et al., 2002), OxyS with fhlA mRNA (Zhang et al., 2002), 
RyhB with sodB mRNA (Afonyushkin, Vecerek, Moll, Blasi, & Kaberdin, 
2005), and SgrS with ptsG mRNA (Kawamoto, Koide, Morita, & Aiba, 
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2006). Moreover, Hfq was found to harbor ATPase activity, raising the 
possibility of ATP-fueled activity (Sukhodolets & Garges, 2003). However, 
ATP is not required for Hfq stimulation of in vitro RNA annealing, nor does 
addition of ATP enables Hfq to non-specifically displace RNA strands 
(Rajkowitsch & Schroeder, 2007a). 
Another well-known group of RNA annealers is the highly-conserved 
double-stranded RNA binding domain (dsRBD) proteins, RNase III family 
proteins Drosha and Dicer being two of the most prominent ones. dsRBD 
proteins can anneal RNA oligos that do not anneal on their own (Hitti, 
Neunteufl, & Jantsch, 1998). 
A third example is the guide RNA targeted RNA annealing. Short 
RNAs can form complex with proteins and direct the RNPs to their target 
RNA sequences and anneal with them. RNA-induced silencing complex 
(RISC) is one of these proteins with an siRNA binding to the argonaute 
protein (Ameres, Martinez, & Schroeder, 2007). Formation of siRNA-
target-RNA complex results in target RNA cleavage and regression of the 
gene expression. 
1.4.4.3 Specific binding proteins 
    Specific binding proteins recognize and bind to specific 
conformations in the RNA structures to facilitate RNA folding. They help 
with formation of functional active sites or intermediate structures (Pontius 
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& Berg, 1992). Many of those protein-RNA co-crystalized X-ray structures 
are available, including the ribosome structure (Brodersen, Clemons, 
Carter, Wimberly, & Ramakrishnan, 2002). Important advances are made 
by studying folding and assembly of ribosomal RNAs with their specific 
proteins (Talkington, Siuzdak, & Williamson, 2005). One of the well-
studied specific binding proteins is the group I intron splicing factor CYT-
18 in N. crassa, whose binding to the specific structural element leading to 
stabilization of the catalytic site of the intron. 
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Chapter 2. Materials and methods 
2.1 Materials 
Oligonucleotide primers were synthesized from Integrated DNA 
Technologies (Coralville, IA). Radiolabeled nucleotides were purchased 
from Pekin Elmer (Waltham, MA). Cloned Pfu DNA polymerase and 
dNTP mixture were obtained from Agilent Technologies (La Jolla, CA). 
Restriction endonucleases were purchased from New England Biolabs Inc. 
(Ipswich, MA) or Promega (Madison, WI). E. coli strains DH5α and BL21 
(DE3) codon PLUS were obtained from Stratagene (La Jolla, CA). 
MEGAscript® T7 Transcription Kit was purchased from Thermo Fisher 
Scientific (Waltham, MA). 
2.2 Yeast strains 
Complementation assays used three yeast null strains QBY320, 
HM410 and HM402 [135, 146, 147] that had a defective ymLeuRS. 
QBY320 (MATa ade2-l ura3-l his3-ll, 15trplA63 leu2-3, 112canl-100 
msllA::HIS3 [p+] (pQB223)) has a genomic deletion of the NAM-2 gene 
encoding ymLeuRS, with an insertion of HIS marker. HM410 (MATa 
ade2-l his3-ll,15 leu2-3,112 trpl-l ura3-l canl-100 nam2A::LEU2 [WT 777-
3A]) and HM402 (MATa ade2-l his3-ll,J5 leu2- 3,112 trpl-l ura3-l canl-100 
nam2A::LEU2 [A introns]) strains also contain a genomic disruption of the 
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ymLeuRS gene but have a LEU marker. The ymLeuRS fused to a MIS 
sequence is encoded from the maintenance plasmids pQB223 and 
YEpGMC063 [146] that also contain a URA3 marker in QBY320 and 
HM410/402, respectively. 
2.3 Site-directed mutagenesis 
Mutations were introduced into the template plasmid via polymerase 
chain reaction (PCR). The 50μl reaction contained 100 ng of template 
plasmid DNA, 125 ng each of forward and reverse primer, 0.05 mM dNTP 
mix, and 0.05 units of Pfu DNA polymerase in commercial buffer. The final 
PCR mixture was restriction-digested with 0.8 units of DpnI for 4 h at 
37 °C and then used to transform E. coli strain DH5α. Plasmid DNA was 
isolated from a 3 ml overnight culture of a single transformant using the 
QIAprep Spin Miniprep Kit (Qiagen Inc., Hilden, Germany). Mutations 
were confirmed by DNA sequencing (UIUC Core Sequencing Facility, 
Urbana, IL). 
2.4 Expression and purification of proteins 
N-terminal six-histidine-tagged proteins were expressed from the 
corresponding plasmids in BL21 (DE3) codon PLUS. A single 
transformant was used to inoculate 3ml LB media, which was then 
incubated at 37 °C overnight. The overnight culture was used to inoculate 
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1L LB culture, which was grown at 37 °C until the OD600 reached 0.6 to 
0.8. Overexpression of the protein was induced with 1mM IPTG and went 
on overnight at room temperature. The bacteria was pelleted at 6000 rpm 
for 10 min at 4 °C by an Avanti J-E (Beckman Coulter, Fullerton, CA) 
preparative centrifuge. 
The bacteria pellet was resuspended with 10 ml HA-I buffer [20 mM 
Na2HPO4, 10 mM Tris (hydroxymethyl) aminomethane (Tris) pH 8.0, 100 
mM NaCl and 5% glycerol]. This was followed by addition of PMSF 
protease inhibitor to around 100 mM final concentration and sonication on 
ice (Vibra-cell 75185, 9 pulses of 10 s at 30% amplitude). The bacteria 
lysate was centrifuged at 12,000 rpm for 30 min at 4 °C. 
The protein-containing clear supernatant was mixed with 1ml of HIS-
Select Nickel Affinity Gel (Sigma-Aldrich) that had been washed three 
times with 10 mL HA-I buffer each time. The N-terminal His-tagged 
protein in the supernatant was bound to the resin via gentle rocking at 4 °C 
for 2 h. Following binding, the resin was washed with 50 mL HA-II buffer 
[20 mM Na2HPO4, 10 mM Tris pH 7.0, 500 mM NaCl, and 5% glycerol] 
at 4 °C. The bound proteins were eluted from the resin using an imidazole 
gradient from 2mM to 500mM in the HA-I buffer. 
Depending on the purity, the eluted fractions that contained the target 
protein were further purified using size-exclusion chromatography. The 
eluted target protein was dialyzed into the storage buffer (50 mM KPi pH 
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7.6, 5 mM MgCl2, 25 mM KCl, 0.1mM EDTA, 5 mM β-mercaptoethanol, 
5mM DTT, 50% glycerol). The final protein concentration was determined 
spectrophotometrically at 280 nm using the corresponding extinction 
coefficient, estimated by the ExPASy Protparam tool 
(http://ca.expasy.org/tools/protparam.html). 
2.5 Transcription of tRNAs in vitro 
The templates for in vitro transcription were prepared via PCR 
amplification. The PCR reaction contained 200 μM dNTPs, 2 μM primers, 
5 μl BSA, 40 ng plasmid that contains the corresponding tRNA gene, 20 U 
Vent polymerase (New England Biolabs Inc., Beverly, MA) in commercial 
buffer at 1 ml total volume. The PCR products were digested with 400 U 
BstNI at 65 °C for 2 hr and then purified using QIAquick PCR purification 
kit. The in vitro transcription reactions contained 40 mM Tris-HCl (pH 8.3), 
20 mM MgCl2, 5 mM dithiothreitol (DTT), 1 mM spermidine, 4 mM each 
NTP (pH 8.0), 0.05 mg/ml BSA, 0.002 units/ml inorganic pyrophosphatase, 
150 ng/μl affinity-purified T7 RNA polymerase (gift from Dr. M. Saks and 
Dr. C. Weitzel, University of Illinois), and 18 ng/μl DNA template. The 
reaction mixtures were incubated for four hours at 40 °C, stopped by 
adjusting the reactions to a final concentration of 25 mM EDTA and 300 
mM sodium acetate (pH 5.3). 
Transcribed tRNAs were precipitated from the reaction for 30 min at -
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20 °C by adding twice the volume of 100% cold ethanol, pelleted at 
maximum speed at 4 °C and resuspended in 50 μl water. The tRNA 
products were purified to single nucleotide resolution by electrophoresis 
on a denaturing 8% polyacrylamide gel, containing 8 M urea. 
Electrophoresis was carried out in 1 X Tris-Borate-EDTA (TBE) buffer (90 
mM Tris, 90 mM boric acid and 2 mM EDTA, pH 8.0) for 6 – 8 hr at 40 
mA [lowered in later stage of electrophoresis to avoid gel overheating]. 
The tRNA bands were visualized via UV shadowing and the bands excised 
from the gel. For every 500 μl in vitro transcription reaction, the tRNAs 
were eluted from the gels at 4 °C in 10 ml elution buffer (200 mM 
potassium acetate, 10 mM EDTA, pH 5.4) with rotation overnight. After 
the eluted tRNA was recovered from the gel fragments using a clinical 
centrifuge, a second 5ml aliquot of the same elution buffer was added to 
elute any tRNA left in the gels for 2 hr. The two elutions were combined, 
and tRNAs were precipitated from the elutions for two days at -20 °C by 
adding 2× volume of 100% cold ethanol. The pellets were then washed 
with 5 ml 75% ethanol, dried and resuspended in NaCl solution with final 
1 M NaCl concentration. An equivalent volume of 100% ethanol was 
added to the resuspended tRNA, which was loaded on a spin cartridge 
(ThermoFisher Scientific, Waltham, MA) and centrifuged at 10,000 g for 
2 min. A 100 μl elution buffer (10 mM Tris pH 7.5, 0.1 mM EDTA) that 
had been pre-heated to 95 °C was added, and centrifuged at 10,000 g for 1 
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min to elute the bound tRNA. The elution procedure was repeated with 
another 100 μl elution buffer and the two elutions were combined to yield 
the final tRNA stock. 
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Chapter 3. Characterization of bI4 intron 
splicing-sensitive regions in leucyl-tRNA 
synthetase 
3.1 Introduction 
During their lengthy evolutionary pathway, aaRSs have evolved a wide 
variety of secondary functions (Lambowitz & Perlman, 1990; Martinis et 
al., 1999) in addition to their housekeeping function in protein synthesis 
(Ibba & Söll, 2000). Among them, two fungal mitochondrial synthetases, 
leucyl-tRNA synthetase (ymLeuRS or NAM2p) in Saccharomyces 
cerevisiae (Herbert et al., 1988; Labouesse, 1990; Labouesse et al., 1985) 
and tyrosyl-tRNA synthetase (TyrRS or CYT-18) in Neurospora crassa 
(Akins & Lambowitz, 1987; Paukstelis & Lambowitz, 2008) aid splicing 
of group I introns from essential respiratory genes. 
The ymLeuRS collaborates with the bI4 maturase for the excision of 
the bI4 and aI4α introns from the cob and coxIα genes respectively 
(Labouesse et al., 1987; Rho & Martinis, 2000). The ymLeuRS gene was 
implicated in intron splicing in yeast complementation experiments when 
a LeuRS missense mutation G240S partially suppressed a splicing 
deficiency caused by a non-functional bI4 maturase mutant (Labouesse et 
al., 1987). More recently, it was shown that ymLeuRS independently 
43 
 
stimulates splicing activity of the bI4 intron, even in the absence of the bI4 
maturase (Rho & Martinis, 2000). 
The ymLeuRS editing domain (connective polypeptide 1 or CP1 
domain) and the C-terminal domain that binds the tRNA elbow were 
identified to contribute to splicing activity (Hsu et al., 2006; Rho et al., 
2002; Sarkar et al., 2012). The CP1 domain independently binds to the bI4 
group I intron to support splicing of the bI4 intron in the absence of the 
full-length protein (Sarkar et al., 2012). The isolated CP1 domain also 
rescued a ymLeuRS deletion yeast strain (Rho et al., 2002). This domain 
contains a hydrolytic active site for amino acid editing (Betha, Williams, 
& Martinis, 2007; M. T. Boniecki et al., 2008). The 3’ end of the 
mischarged tRNA binds to this threonine-rich area to hydrolyze the 
mischarged amino acid on the tRNA (Lincecum et al., 2003). A splicing-
sensitive site at Trp238 was discovered on the β-strands that connect the 
CP1 domain to the main body of ymLeuRS and was characterized both in 
vivo and in vitro (Labouesse et al., 1987; Sarkar et al., 2012). Since Trp238 
interacts with the tRNA during the editing reaction (Nawaz, Pang, & 
Martinis, 2007), it was hypothesized that other splicing sensitive sites 
should be identified within or in proximity to the editing active site on the 
CP1 domain. 
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3.2 Experimental procedures 
3.2.1 Strains and strain constructions. 
A suppressor mutation called NAM2-B2 was isolated that rescues 
splicing activity and respiration in a yeast strain that expressed a bI4 
maturase which has been inactivated by the bI4 PZ16 mutation (a 
frameshift mutation in the middle of the intron reading frame). Strain PZ16 
is a respiration-deficient (gly-) mutant derived from strain ID41-6/161 
(MATa ade1 lys1) (Anziano, Hanson, Mahler, & Perlman, 1982). Like the 
NAM2-1 mutation of the LeuRS gene (Dujardin, Pajot, Groudinsky, & 
Slonimski, 1980), it partially restores bI4 and aI4 splicing, is dominant or 
semi-dominant and is linked to the URA4 gene. The mutation in the NAM2-
B2 allele of the ymLeuRS gene was defined by sequencing the gene 
following PCR amplification and cloning of a BamHI fragment containing 
the reading frame. A single genetic mutation (A818G) was found, which 
changes Gln273 (CAG) to arginine (CGG) in ymLeuRS. 
Plasmid pBLSMSL contains the wild-type NAM2 1.1 kb BamHI 
fragment from strain 161 (above) cloned into the pBLSK+ vector 
(Stratagene Corp., San Diego, CA). Site-directed mutagenesis was used to 
introduce the A818G mutation into plasmid pBLSMSL to generate plasmid 
pBSB2. pBSB2 DNA was digested with BamHI and the fragment 
containing the NAM2 gene was isolated, mixed with a PCR product 
45 
 
containing the URA3 gene and used to co-transform a ρo derivative of strain 
a161U7 (MATa ade1 lys1 ura3). Uracil prototrophs were selected and 
screened for the presence of the gene carrying the NAM2-B2 mutation by 
mating to strain αMCC109/(MATαkar1-1 ade2 ura3) with CI34-PZ25 
mtDNA (Henke, Butow, & Perlman, 1995) and testing for haploid cells that 
can grow on glycerol medium. One of those strains, 161-NAM2-B2/CI34-
PZ25 was isolated and used here; the PZ25 mutation is an in-frame stop 
codon near the beginning of mature bI4 maturase. DNA sequencing 
following PCR amplification confirmed the presence of the NAM2-B2 
mutation in that strain. Strain 161-NAM2-1/CI34-PZ25 was constructed 
analogously, starting with a site-directed mutation of the cloned wild-type 
LeuRS gene. The 161-NAM2-B2/CI34-PZ25, 161-NAM2-1/CI34-PZ25 
and 161/CI34 ρ+ strains all grow comparably well on glycerol medium. 
3.2.2 Plasmid construction and mutagenesis for protein 
purification 
The plasmid p14MB-ymLeuRS-WT (M.T. Boniecki, 2007) was used 
to express wild-type ymLeuRS. This plasmid was also used as the template 
to introduce point mutations at Gln273 with primers ym-Fwd-(Q273A) (5’-
CCGGAAACTCTTTTTGCTGTAGCGTATGTTGCTCTCGCATTAG-
3’), ym-Fwd-(Q273R) (5’-CGGAAACTCTTTTTGCTGTACGTTATGTT 
GCTCTCGCATTAGAC-3’), ym-Fwd-(L277A) (5’-GCTGTACAGTAT 
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GTTGCTGCGGCATTAGACCACCCAATTG-3’), to generate plasmids 
encoding the ymLeuRS that contained Q273A, Q273R, L277A mutations 
respectively via PCR reactions. Mutations were confirmed by DNA 
sequencing (UIUC Core Sequencing Facility, Urbana, IL). 
3.2.3 Complementation of yeast mitochondrial LeuRS null 
strains. 
Mutations were introduced via PCR into plasmid pQB184 for 
complementation assays with QBY320 (MATa ade2-1 ura3-1 his 3-11,15, 
trp1Δ63 leu2-3, 112 an1-100 msl1Δ::HIS3 [ρ+] (pQB223). For 
complementation experiments with HM402 (MAT ade2-1 his3-11,15 leu2-
3,112 trp1-1 ura3-1 can1-100 nam2Δ::LEU2 [introns]), HM410 (MATα 
ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1-100 nam2Δ::LEU2 [wt 
777-3A], and HM411 (MATΔade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 
can1-100 nam2Δ::LEU2 [box7 mutant (V328)] (G. Y. Li et al., 1996; 
Seraphin, Boulet, Simon, & Faye, 1987), a derivative of the plasmid 
pQB184/Trp was used which contained either wild-type or mutant LeuRS 
genes. The pQB184/Trp plasmid was obtained by excising the LEU2 
marker from a pQB184 derivative (containing either the wild-type or 
mutant LeuRS gene) by a restriction digest with ScaI and NsiI and 
subsequently introducing a TRP1 marker. The TRP1 gene was obtained 
from Yeplac112 (Sugino & Gietz, 1988) via the same restriction digestion 
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with ScaI and NsiI. Details of the complementation experiments for each 
set of strains and plasmids have been described previously (Houman et al., 
2000). 
3.2.4 Expression and purification of proteins 
Wild-type or mutant ymLeuRS proteins were expressed from the 
respective plasmids in BL21 (DE3) codonPLUS competent cells (Agilent 
Technologies, Santa Clara, CA) as described in Chapter 2, except that the 
HA-I and HA-II buffers were supplemented with 50 mM and 250 mM KCl 
respectively. 
3.2.5 Precursor RNA Transcription 
Plasmid pM96Δhj1-3 encodes the gene for the shortest bI4 intron 
deletion mutant bI4Δ1168 precursor RNA (pre-RNA) that has been shown 
to be catalytically active in vitro (M. T. Boniecki et al., 2009). A custom 
made RNA ladder ranging from 50 to 250 base pairs was used for analyzing 
the splicing products by gel electrophoresis. Plasmids pUC8MB-250, 
pUC8MB-200, pUC8MB-150, pUC8MB-100, and pUC8MB-50 (M. T. 
Boniecki et al., 2009) encode specific RNAs ranging from 250 to 50 base 
pairs. Each plasmid was isolated from E. coli strain DH5α using a Qiagen 
Plasmid MegaPrep kit-25 (Qiagen, Hilden, Germany). This is followed by 
restriction digest with either BamHI for the bI4Δ1168 RNA or SalI for the 
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ladder RNAs. RNA was transcribed using a T7 MEGAscript kit (Thermo 
Fisher Scientific, Waltham, MA) and 1 μg DNA template at 37 °C for 6 h 
in a 20 μl reaction. Radiolabeled RNA was obtained by incorporating 10 
μCi of [α-32P]-UTP. The bI4Δ1168 pre-RNA was isolated using Chroma 
Spin-200 + DEPC-H2O columns (Clontech Laboratories, Inc., Mountain 
View, CA). RNA concentration was estimated optically, based on its 
extinction coefficient, calculated by the online ambion oligonucleotide 
calculator. The bI4Δ1168 pre-RNA was folded in vitro at 50 °C for 2 min 
followed by cooling at 37 °C for 10 min. The ladder RNA fragments were 
isolated by phenol:chloroform:isomyl alcohol [125:24:1] extraction 
followed by ethanol precipitation. The recovered RNA pellet was washed 
with 70% ethanol, vacuum-dried, and then dissolved in 50–100 μl of 
nuclease-free water (Invitrogen Corp., Carlsbad, CA). 
3.2.6 LeuRS-dependent in vitro splicing assay 
The in vitro splicing reaction included 1 μM [32P]-labeled bI4Δ1168 
pre-RNA (0.13 μCi/μl), 1 μM LeuRS, 150 mM KCl, Stop RNase inhibitor 
(5 Prime, Inc., Gaithersburg, MD) in 1× splicing buffer (10 mM Tris, pH 
7.5, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, and 10% glycerol). The 
reaction was carried out at 37 °C and initiated with 1 mM guanosine. 
Aliquots of 10 μl were quenched in 10 μl of 5 M urea, 30 mM EDTA, and 
mixed with 5 μl of RNA loading dye. The mixture was incubated for 10 
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min at 65 °C and then electrophoresed on a 6% denaturing polyacrylamide 
gel overnight at 10 mA in 1×Tris/Borate/EDTA (TBE) buffer. The gel was 
dried and phosphorimaged using a FUJIFILM BAS Cassette 2040 
(FUJIFILM Medical Systems, CT). 
Products were visualized by scanning the images using a STORM 840 
Molecular Dynamics scanner (Amersham Biosciences). Images were 
quantified with ImageQuant software. Bands representing the precursor 
RNA, excised intron, and ligated exons were normalized for each time 
point by determining the fraction of each band relative to the sum intensity 
of the three bands. In addition, background was subtracted based on the 
zero time point. Extent of reaction (product/total bands in each lane) was 
calculated using GraphPad Prism 5 via its single exponential function as 
described previously (M. T. Boniecki et al., 2009). 
3.2.7 Protein-RNA binding assay 
Nitrocellulose membranes (0.45 μM), nylon membranes (0.45μM) and 
blotting papers were pre-incubated in binding buffer (10 mM Tris-HCl pH 
7.5, 100 mM NaCl, 5 mM MgCl2, 5 mM DTT, 1 mM EDTA, 100 μg/ml 
BSA, 10% glycerol). Each 250 μl binding reaction contained 100 nM [α-
32P]-UTP labeled RNA, increasing concentrations of 0 to 500 nM WT or 
mutant LeuRS, and small amounts of heparin (10 μg/ml). The reactions 
were incubated in binding buffer for 1 h at 37 °C. Solutions were filtered 
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through nitrocellulose membrane and nylon membrane under vacuum 
pressure, air dried and then visualized using a phosphorimager as described. 
Dots on the nitrocellulose membrane represent protein-RNA complex, 
while dots on the nylon membrane represent unbound RNAs. The KD was 
calculated by fitting the data as follows: 
Y =  
KD + Bmax + X − √(KD + Bmax + X)2 − 4 × Bmax × X
2
× Bmax 
where Bmax is the maximal binding (GraphPad Prism 5, San Diego, CA). 
3.3 Results 
3.3.1 Characterization of a CP1-based splicing sensitive site 
The LeuRS house keeping protein was first identified for its role in 
group I intron splicing, when a G240S LeuRS mutation NAM2-1 was found 
to rescue a bI4 maturase deficiency (Dujardin et al., 1980). However, we 
wondered if there are other regions of LeuRS that are important to its 
splicing activity. As such, we screened for suppressor mutations of a bI4 
maturase-deficient strain. One mutation called NAM2-B2, exhibited 
somewhat different properties from the NAM2-1 suppressor. In particular, 
the strain containing NAM2-B2 is temperature-sensitive for glycerol 
growth (data not shown) while the NAM2-1 strain was temperature 
resistant, suggesting that the B2 mutation was a novel suppressor. Linkage 
to URA4 and 2/2 segregation of glycerol growth from a B2/Δmsl PZ25 
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diploid established that the B2 mutation was an allele of the NAM2 gene.  
Sequencing the gene from the mutant strain revealed a single DNA 
point mutation, A818G, that changes Gln273 in LeuRS to arginine. We 
introduced A818G mutation into the wild-type gene by site-directed 
mutagenesis followed by transformation and confirmed that it suppresses 
the gly- phenotype of a strain carrying the PZ25 bI4 maturase mutation. For 
comparison, we also constructed a related strain with the NAM2-1 mutation 
(G240S LeuRS). Both the Q273R and G240S mutant LeuRS suppressed 
strains grown similarly on glycerol medium. Northern blot analysis shows 
that the NAM2-B2 and NAM2-1 mutations rescue the bI4 maturase defect 
similarly, splicing approximately 30% of the coxI transcripts to yield a 1.9 
kb mature coxI transcript (Figure 3.1). 
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Figure 3.1 Northern blot analysis of NAM2 mutant suppression of bI4 
maturase-based splicing defects. Total cellular RNA was isolated from 
each yeast strain and separated on a 1.2% denaturing agarose gel. The RNA 
was transferred for Northern blot analysis, probed with an exon 4-specific 
oligonucleotide, and quantitated using a Molecular Dynamics 
phosphorimager. Pre-mRNA and processed mRNA with the bI4 intron 
excised are marked with arrows respectively at 3.0 kb (upper band) and 1.9 
kb (lower band). Lane 1 contains spliced and unspliced RNA from yeast 
strain CI34, a wild-type control. Lane 2 shows only unspliced pre-RNA 
from a mitochondrial splicing-defective yeast strain CI34-PZ25 that 
contains a mutation in the bI4 maturase. Lane 3 demonstrates rescue of the 
CI34-PZ25 splicing defect by NAM2-1. Lane 4 shows suppression of the 
CI34-PZ25 splicing defect by NAM2-B2.  This figure is cited from 
(Henke, 2000). 
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3.3.2 Mutational characterization of the Gln273 suppressor 
site. 
In previous experiments, we showed that mutation of Gln273 to alanine 
inactivated CP1-dependent splicing (Rho et al., 2002). Herein, we 
mutationally analyzed the Gln273 site within wild-type (WT) ymLeuRS 
defined by the NAM2-B2 mutation by introducing other charged residues 
including lysine and glutamic acid. Growth tests in a strain that is disrupted 
for the mitochondrial LeuRS gene (msl1) (Houman et al., 2000), but has 
WT mtDNA showed that mutations of Gln273 to a charged residue support 
splicing and mitochondrial translation (based on growth on glycerol) while 
the Q273A allele is defective for one or both functions (Figure 3.2). 
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Figure 3.2 Complementation of a yeast strain that contains a null allele 
of the gene encoding LeuRS. Strain QBY320 was transformed with 
plasmids that expressed wild-type or various mutant LeuRS genes that 
contained a substitution at the Gln273 position as indicated. Transformants 
were purified on 5-fluororotic acid to remove the maintenance plasmid 
pQB223. The null strain was then tested for grown on glycerol (A.) or 
glucose (B.) media as described previously. Growth on glycerol medium 
(white circles) demonstrates that mitochondrial function has been 
complemented.  This work was carried out by S.B. Rho. 
 
    We also investigated each of the four Gln273 LeuRS mutations using 
a series of Δmsl1 yeast null strains with diagnostic mitochondrial 
genotypes. Similar to QBY320, HM410 is a wild-type strain. However, its 
derivative strain HM402 has no introns in its mtDNA and thus does not 
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rely on RNA splicing for respiratory growth. A third related strain HM411 
contains a bI4 maturase mutation that blocks bI4 and aI4α intron splicing. 
Because some reported LeuRS mutations are temperature sensitive for 
complementation activity, growth was tested at both 28 oC and 36 oC. Both 
the Q273R LeuRS suppressor mutant (NAM2-B2) and the original G240S 
LeuRS suppressor mutant (NAM2-1) complemented the strain lacking the 
bI4 maturase (HM411) strain at both temperatures demonstrating that they 
compensate for a defective maturase. Neither the lysine, nor the glutamic 
acid substitutions suppress the bI4 maturase defect (Figure 3.3). However, 
the Q273K and Q273E mutant LeuRSs support glycerol growth of the 
wild-type, intron-containing strain HM410 showing that they effectively 
collaborate with the bI4 maturase splicing function. As would be expected, 
these alleles support glycerol growth of the intronless strain, demonstrating 
that they support LeuRS aminoacylation activity. 
Previously, we used three-hybrid assays to determine that the Q273A 
LeuRS mutant does not bind to the bI4 intron, and thus fails to facilitate 
the essential splicing activity (Rho et al., 2002). Surprisingly, the Q273A 
mutant allele does not complement the HM402 intronless strain (Figure 
3.3), showing that the mutation not only impedes splicing activity, but also 
strongly inhibits its function in translation. Thus, the Gln273 site is critical 
to the enzyme’s protein synthesis activity in the yeast mitochondria as well 
as the RNA splicing activity. 
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Figure 3.3 Complementation of yeast null strains that contain 
mitochondrial genome variations. Each of the three null strains have a 
deletion in the nam2 allele. The upper row of each plate tested 
complementation activity of a yeast mitochondrial null strain (HM402) that 
completely lacks mitochondrial introns (ΔΣ introns). The middle row of 
each plate represents a null strain (HM410) with a wild-type mitochondrial 
genome that contains each of the 13 introns. The lower row of each plate 
tests a null strain that also has a mutant bI4 maturase (V328), which is 
defective in splicing activity. The plates were incubated on glycerol 
medium at either 28oC (upper plate) or 36oC (lower plate) as described 
previously (G. Y. Li et al., 1996).  This work was carried out by S.B. Rho. 
3.3.3 The Gln273 suppressor site modulates RNA binding 
We purified the splicing suppressor Q273R LeuRS, as well as the 
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splicing inactive Q273A LeuRS to test their splicing activity in vitro. 
Similar to in vivo complementation results, Q273A mutant exhibited 
significantly reduced processing of the bI4Δ1168 pre-RNA. The extent of 
formation of the splicing products bI4 intron and B4-B5 ligated exons was 
greatly decreased, as compared with the WT ymLeuRS. In contrast, the 
Q273R mutant showed similar intron splicing activity as WT ymLeuRS 
(Figure 3.4 and Figure 3.9). 
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Figure 3.4 Reaction extent for in vitro bI4Δ1168 splicing activity of 
ymLeuRS Gln273 mutants. The processing of the bI4Δ1168 pre-RNA 
was evaluated with respect to substrate pre-RNA processing (A.), fraction 
of bI4 excised intron (B.), and fraction of the ligated B4-B5 exons (C.). 
Calculations were based on the intensity of the phosphorimaged bands for 
the substrate and products bI4 and B4-B5 as well as other alternate bands 
that emerged during the reaction. Splicing reactions incorporated 1 μM 
substrate pre-RNA and 1 μM LeuRS and were initiated with 1 mM 
guanosine. Symbols are: (●), Q273R; (■), Q273A.  Error bars for each 
time point result from each reaction repeated in triplicate. 
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We also determined binding interactions of LeuRS mutants Q273R and 
Q273A with the bI4 intron using nitrocellulose binding assay. As would be 
expected from previously published three-hybrid assays (Rho et al., 2002), 
the Q273A LeuRS mutant yielded a higher KD than WT ymLeuRS for its 
interactions with bI4Δ1168 pre-RNA. In contrast, the Q273R LeuRS 
mutant yielded a similar KD as WT LeuRS (Table 3.1). In three-hybrid 
analysis, each of the Q273R, Q273K, and Q273E mutant LeuRSs bound 
likewise to the bI4 intron (Figure 3.5A). 
To confirm the in vitro splicing assay results, we isolated RNA from 
the yeast nucleus of the three-hybrid cells and used RT-PCR to amplify 
spliced product and the unspliced RNA precursor. In the presence of the 
Q273R, Q273K, or Q273E mutant LeuRSs, a faint band at 250 bp was 
produced, supporting that each of these mutant proteins could stimulate bI4 
intron splicing in the nucleus (Figure 3.5B). As would be expected, in the 
absence of LeuRS or the presence of the Q273A mutant LeuRS, spliced 
product was not detected. We isolated protein from the yeast nucleus of the 
three-hybrid cells and showed that the Q273A LeuRS mutant is expressed 
and imported into the yeast nucleus at similar levels to the wild-type 
protein (Figure 3.5C). Thus, we propose that splicing deficiency of Q273A 
mutant is the result, at least in part, of compromised binding between the 
protein and the intron, and that the Q273 site within the CP1 domain of 
LeuRS is important to splicing activity of the enzyme. 
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Figure 3.5 Three-hybrid analysis of LeuRS Gln273 mutant-dependent 
binding and splicing activity of the bI4 intron. A. Three-hybrid binding 
interactions between the bait bI4 intron fused to the MS2 RNA and wild-
type and mutant LeuRS prey that are fused to the B42 activation domain 
(Rho & Martinis, 2000). Blue color (dark circle in the figure) developed in 
each case, except when the parent vector control or the Q273A LeuRS were 
introduced as prey. B. RT-PCR analysis of bI4 intron spliced product. RNA 
isolated from the nucleus of the L40uraMS2 yeast host was amplified by 
RT-PCR and separated on 1% agarose gels. DNA markers (not shown) 
identified bands at about 1.5 kb representing unspliced bI4 intron and faint 
bands at 250 base pairs, marked by white triangles that indicate spliced 
product. C. Western blot of B42 fused wild-type and Q273A mutant LeuRS. 
Nuclear proteins were extracted from the L40uraMS2 host cells used in the 
three-hybrid analysis. Anti-V5 antibody was used to detect a 14 amino acid 
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V5 epitope that is present in each of the prey proteins. A series of protein 
standards (data not shown) identified the yeast mitochondrial LeuRS band 
at approximately 120 kDa.  This work was carried out by S.B. Rho. 
 
Table 3.1 RNA equilibrium binding constants for wild type 
and ymLeuRS mutants with bI4Δ1168 
ymLeuRS KD (nM)a 
WT 17 ± 11 
Q273R 15 ± 10 
Q273A 35 ± 23 
L277A 36 ± 23 
aStandard error is based on measurements 
that were repeated at least in triplicate. 
3.3.4 Alanine scan of the Gln273 splicing suppressor region 
identifies a second splicing-sensitive site 
A LeuRS primary sequence alignment of the neighboring amino acid 
sites of Gln273 show that it is not conserved (Figure 3.6). Indeed, the 
glutamine residue is only found in the mitochondrial enzyme from another 
fungus, Neurospora crassa. Upstream is a threonine-rich region that has 
been shown to be important for the amino acid specificity in LeuRS’s 
hydrolytic editing activity (Mursinna, Lincecum, & Martinis, 2001). 
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Further downstream (not shown) is another conserved region that 
comprises a portion of the enzyme’s editing active site. 
We performed alanine-scanning mutagenesis of the region containing 
Q273, as indicated in Figure 3.6, to screen for other sites in proximity to 
this amino acid editing region that might also affect bI4 splicing. The five 
non-alanine residues were individually mutated to alanine and tested for 
complementation using the QBY320Δmsl strain that lacked yeast 
mitochondrial LeuRS (Figure 3.7). Only one mutation, L277A, blocked 
complementation. We also tested each of these LeuRS alanine mutants for 
protein-RNA interactions with the bI4 intron via three-hybrid assays. With 
the exception of the L277A LeuRS mutant, each of the mutant LeuRSs 
bound to the bI4 intron and stimulated splicing activity based on RT-PCR 
analysis. We analyzed protein expression and import levels for the L277A 
LeuRS in this system and determined that the L277A mutant LeuRS was 
present at a level that approximates that of the wild-type LeuRS (Figure 
3.8). This supports that the structural integrity of the LeuRS mutant is 
largely intact. It also supports that the Leu277 site influences the bI4 
interaction. 
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Figure 3.6 Primary sequence alignment of the Gln273 splicing 
suppressor region within the CP1 domain of LeuRS proteins. Yeast 
mitochondrial LeuRS (Scm) is shown at the top. Amino acid residues that 
are conserved or homologous to the yeast mitochondrial LeuRS sequence 
are highlighted in black or grey, respectively. An upstream threonine-rich 
region is critical to the enzyme’s hydrolytic editing activity (Mursinna et 
al., 2001; Mursinna & Martinis, 2002). The abbreviations are as follows: 
Sc, S. cerevisiae; Nc, N. crassa; Hs, Homo sapiens; Tth, Thermus 
thermophilus; Bs, Bacillus subtilis; Ec, Escherichia coli; c, cytoplasmic; 
and m, mitochondrial. 
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Figure 3.7 Complementation of QBY320 by alanine-scanned 
mutations in the Gln273 splicing suppressor region. The experiments 
were carried out as described in Figure 3.2. The null strain was tested for 
growth on media that contained glycerol (A.) or glucose (B.).  This work 
was carried out by S.B. Rho. 
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Figure 3.8 Three-hybrid analysis and splicing activity of the alanine-
scanned mutation in the Gln273 splicing suppressor region. 
Experiments were carried out as described in Figure 3.5. A. Cells that 
exhibit β-galactosidase reporter activity are blue (or dark) colored 
indicating that the mutant LeuRS prey protein interacts with the bI4 intron. 
B. RT-PCR analysis. A faint band highlighted by a white triangle represents 
the spliced product at 250 base pairs. Unspliced bI4 intron is represented 
by a band at about 1.5 kb. A diffuse band near the bottom of the gel is due 
to excess primers. Band sizes were determined by two different sets of 
DNA markers shown in the outside lanes. C. Western blot of B42 fused 
wild-type and L277A mutant LeuRS.  This work was carried out by S.B. 
Rho. 
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As would be expected from in vivo experiments, affinity-purified 
L277A LeuRS mutant exhibited significantly reduced processing of the 
bI4Δ1168 pre-RNA. The extent of formations of the bI4 intron and B4-B5 
ligated exons products in vitro was greatly decreased compared with WT 
ymLeuRS (Figure 3.9). In addition, nitrocellulose binding assay showed 
that binding between the L277A mutant and the bI4 intron is compromised 
compared with WT ymLeuRS (Table 3.1). The two-fold change of KD in 
binding has dramatic effects on splicing activity in vivo. 
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Figure 3.9 Reaction extent for in vitro bI4Δ1168 splicing activity of 
ymLeuRS L277A mutant. The processing of bI4Δ1168 pre-RNA was 
evaluated with respect to substrate pre-RNA processing (A.), fraction of 
bI4 excised intron (B.), and fraction of the ligated B4-B5 exons (C.). 
Splicing reactions incorporated 1 μM substrate pre-RNA as well as 1 μM 
LeuRS and were initiated with 1 mM guanosine. Symbols are: (●), WT; 
(■), L277A.  Error bars for each time point result from each reaction 
repeated in triplicate. 
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3.4 Discussion 
The bifunctional LeuRS is not only required for protein synthesis (Ibba 
& Söll, 2000; Pang et al., 2014; Ribas de Pouplana & Schimmel, 2001a), 
but also in excision of bI4 and aI4α group I introns of the cob and coxIα 
pre-mRNAs respectively in yeast mitochondria (Slonimski et al., 1978). 
The mitochondria-encoded bI4 maturase and the nuclear-encoded LeuRS 
work in concert as a ternary complex onto the bI4 intron to promote 
splicing (M. T. Boniecki et al., 2009; Herbert et al., 1988; Labouesse, 1990; 
Labouesse et al., 1985; Rho & Martinis, 2000). A direct role of LeuRS in 
splicing has been established, where LeuRS independently binds to the bI4 
intron and facilitates splicing both in vivo and in vitro (M. T. Boniecki et 
al., 2009; Rho & Martinis, 2000). Here we show that intron binding is 
modulated, at least in part, by a discrete region of the CP1 domain that is 
distinct from its editing active sites. 
The structure of ymLeuRS was modeled based on the X-ray structure 
of EcLeuRS (Palencia et al., 2012; Rho et al., 2002). The splicing sensitive 
Gln273 and Leu277 sites in the structure are located on the two ends of the 
β3 strand in the CP1 domain. The Gln273 site is located on the surface 
while Leu277 is buried (Figure 3.10). We hypothesized that Gln273 
provides critical direct contact with the intron via its polar group. Thus, 
substitution of charged arginine (Q273R) rescued splicing deficient bI4 
maturase by stabilizing ymLeuRS interaction with the bI4 intron. We 
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hypothesized that Leu277 impacts splicing by sterically positioning the β3 
strand along an orientation to optimize Gln273-dependent splicing. In 
proximity to Gln273, potential intron binding sites are identified on the 
surface of the CP1 domain, including two positively-charged residues as 
well as several polar but uncharged residues. These amino acids are 
proposed to comprise the intron face of the CP1 domain. Interestingly, this 
intron face is distinct from the tRNA face where tRNA binding sites are 
centralized on the CP1 domain, and suggests that at least a portion of the 
intron binding face has evolved independent of the LeuRS tRNA binding 
face. This is similar to TyrRS from N. crassa, which also has the intron and 
tRNA binding sites on two distinct sides of the protein (Paukstelis et al., 
2008). 
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Figure 3.10 bI4 intron face is distinct from the editing face of the 
LeuRS CP1 domain. The ymLeuRS structure is modeled from the X-ray 
structure of EcLeuRS. A. Gln273 (red) and Leu277A (orange) are located 
at the two ends of the β3 strand (purple). Editing sensitive sites are colored 
in green. B. Intron face and editing face are located on opposite sides of 
the LeuRS CP1 domain. The intron face is composed of Gln273 (red), 
positively charged K371 and H369 (pink) and polar but uncharged T372, 
S413 and T324 (yellow). The editing face is colored in green. 
 
Although LeuRSs from different origins could facilitate bI4 intron 
splicing (Houman et al., 2000), the CP1 domain of ymLeuRS has diverged 
to optimize splicing of the bI4 intron in yeast mitochondria. The CP1 
domain along with its two connecting β-strands (ymCP1-βext) stimulates 
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intron splicing both in vivo and in vitro, whereas compromised in 
deacylation activity (Sarkar et al., 2012). It is curious that the robust post-
transfer editing activity of ymLeuRS appears to be dispensable to cell 
survival. Significantly, human mitochondrial LeuRS has completely lost its 
editing function (Lue & Kelley, 2007). It is possible that yeast 
mitochondria has evolved to tolerate increased translational infidelity or 
alternatively has acquired specificity in the aminoacylation site to increase 
fidelity via a different mechanism. It is implicated that the ymLeuRS has 
devoted its CP1 domain more to facilitate intron splicing than tRNA editing. 
72 
 
Chapter 4. Identification of splicing sensitive 
sites in non-splicing E. coli leucyl-tRNA 
synthetase 
4.1 Introduction 
Yeast mitochondrial leucy-tRNA synthetase (ymLeuRS) has two 
essential functions: aminoacylation and splicing of bI4 and aI4α introns 
(Pang et al., 2014). Escherichia coli (Ec), Mycobacterium tuberculosis 
(Mtb) and human mitochondrial (hm) LeuRS have been shown to substitute 
in both functions for ymLeuRS in vivo (Houman et al., 2000). Among them, 
EcLeuRS has been shown to have comparable bI4 intron splicing activity 
as ymLeuRS in in vitro splicing assay (Sarkar et al., 2012). The above 
discoveries indicate that features responsible for splicing function of 
ymLeuRS is broadly conserved in different organisms. Furthermore, the 
CP1 domain as well as the C-terminal domain have been identified to be 
involved in ymLeuRS splicing (Hsu et al., 2006; Rho et al., 2002; Sarkar 
et al., 2012). The ymLeuRS CP1 domain alone is sufficient to perform bI4 
intron splicing function in vivo (Rho & Martinis, 2000) and in vitro (Sarkar 
et al., 2012). In contrast, the CP1 domain of EcLeuRS lacks splicing 
function (Sarkar et al., 2012). This infers that not only universal sites but 
also unique sites on ymLeuRS and EcLeuRS respectively are utilized to aid 
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intron splicing. For ymLeuRS, one of those unique sites is a Q273 region 
on the CP1 domain, which lacks corresponding conserved sites in 
EcLeuRS. This Q273 region of ymLeuRS has been identified to be splicing 
sensitive both in vivo and in vitro (Chapter 3). 
On EcLeuRS CP1 domain, there is a highly conserved threonine-rich 
region that contributes to editing activity of LeuRS (Figure 4.1). Within 
this region a conserved T252 residue acts as a key amino acid discriminator 
to block cognate leucine from binding (Mursinna et al., 2001), but allows 
binding and hydrolytic editing of other non-cognate amino acids. Within 
the EcLeuRS CP1 domain, a second less conserved region downstream of 
the threonine-rich region also appears to influence editing activity. In this 
less conserved region, A293 residue’s role in aminoacylation and fidelity 
was discovered by mutational and computational characterization of 
EcLeuRS (J. F. Chen, Li, Wang, & Wang, 2001; Du & Wang, 2002, 2003; 
Lee & Briggs, 2004; T. Li, Guo, Xia, Wang, & Wang, 1999). Specifically, 
the A293D mutation rescues post-transfer editing deficiency in T252Y 
mutant presumably by activating a pre-transfer editing pathway (Williams 
& Martinis, 2006). Herein, we demonstrate that A293 is also a splicing 
sensitive site for EcLeuRS. 
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Figure 4.1 Multiple sequence alignments of LeuRSs from diverse 
origins spanning the semi-conserved alanine. Grey shading indicates the 
semi-conserved site. Abbreviations are as follows: Yeast mitochondria 
(Scm), E. coli (Ec), M. tuberculosis (Mtb), human mitochondria (Hm) and 
T. thermophilus (Tt).  This figure is cited from (Poruri, 2007). 
4.2 Materials and methods 
4.2.1 Cloning and PCR mutagenesis 
The E. coli LeuRS (EcLeuRS) gene in the resultant clone pRicE1, was 
out of frame with respect to the mitochondrial import sequence (MIS) and 
a stop codon was generated after the MIS (Figure 4.3A). The plasmid clone 
pRicE1 was used as a template to generate mutant clones using site directed 
mutagenesis by PCR. Denaturation was carried out at 95°C for 30 s 
followed by annealing at 55 °C for 30 s and then extension at 68 °C for 20 
min. After 16 cycles, the PCR reaction was incubated at 68 °C for 20 min. 
Each mutation was confirmed by DNA sequencing (Seqwright, Houston, 
USA). The PCR mutagenesis was used to generate the plasmids 
pMPA293D*e, pMPA293K*e and pMPA293R*e that contained A293D, 
A293K and A293R mutations in EcLeuRS respectively. The frame shift 
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within the pRicE1 was corrected to generate the plasmid pKIRAN 
(Karkhanis, Boniecki, Poruri, & Martinis, 2006) that expressed EcLeuRS 
gene in-frame with MIS. The plasmid pKIRAN was utilized in PCR 
mutagenesis to generate pMPA293D, pMPA293K and pMPA293R 
plasmids that expressed A293D, A293K and A293R EcLeuRS mutant 
proteins in-frame with MIS. 
4.2.2 Yeast complementation assays. 
Complementation assays used two yeast null strains, HM410 and 
HM402 that had a defective ymLeuRS. Competent cells for the null strains 
HM410 and HM402 were transformed with plasmids pKIRAN, 
pMPA293D, pMPA293K and pMPA293R encoding wild type EcLeuRS, 
A239D, A293K and A293R mutant EcLeuRSs respectively or with 
pMPA293D*e, pMPA293K*e and pMPA293R*e encoding the mutant 
proteins that were expressed out-of-frame with respect to the MIS. 
4.2.3 Plasmids used in protein purification and RNA in vitro 
transcription 
The following plasmids are used to express proteins and transcribe 
RNAs for the in vitro splicing assays. 
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Table 4.1 Plamids used in protein expression 
     and RNA in vitro transcription 
Protein/RNA encoded Plasmid name Reference 
EcLeuRS-WT p14MB-EcLeuRS-WT (M.T. Boniecki, 2007) 
EcLeuRS-A293D p14MB-EcLeuRS-A293D (M.T. Boniecki, 2007) 
EcLeuRS-A293K p14MB-EcLeuRS-A293K (M.T. Boniecki, 2007) 
EcLeuRS-A293R p14MB-EcLeuRS-A293R (M.T. Boniecki, 2007) 
bI4Δ1168 pre-mRNA pM96Δhj1-3 (M. T. Boniecki et al., 2009) 
4.2.4 Protein purification 
Plasmids expressing the desired proteins (Table 4.1) were used to 
transform E. coli BL21 (DE3) codon plus strain (Agilent Technologies, 
Santa Clara, CA). Bacteria cultures were grown at 37°C and were induced 
with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for protein 
expression at room temperature overnight. The N-terminal six-histidine-
tagged fusion protein was purified and quantified as described in Chapter 
2. 
4.2.5 Circular Dichroism (CD) 
CD measurements were carried out using a Jasco J-720 
spectropolarimeter. A sample containing 0.8 μM protein in 5 mM KPi, pH 
7.5, was measured in the far-ultraviolet region using a 0.1 cm path cell. 
Background signals from the cell and the buffer were subtracted from each 
spectrum. 
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4.2.6 Transcription of tRNAs in vitro 
About 500 μg of the plasmid DNA was digested for 6 h at 60°C with 
25 U of with BstNI to linearize the plasmid. The digested plasmid was used 
as a template for an in vitro transcription reaction containing 40 mM Tris 
(pH 8.0), 30 mM MgCl2, 5 mM DTT, 0.01% Triton-X 100, 50 pg/ml BSA, 
7.5 mM each of ATP, GTP, CTP and UTP, 80 mg/ml polyethylene glycol 
8000 (PEG 8000), 5 mM spermidine, 40 U/ml RNAase inhibitor 
(Eppendorf, Hamburg, Germany), 8 μg/ml inorganic pyrophosphatase 
(PPiase), and 800 nM T7 RNA polymerase (Milligan, Groebe, Witherell, 
& Uhlenbeck, 1987; Sampson & Uhlenbeck, 1988). The reaction mixture 
was incubated for 3 h at 42°C, followed by a second addition of 800 nM 
T7 RNA polymerase, which was then incubated for an additional 3 h at 
42°C. 
The tRNA was purified on a 10 % polyacrylamide (19:1), 8 M urea 
denaturing gel. The tRNA band was detected via UV shadowing, excised 
from the gel followed by extraction in 500 mM ammonium acetate and 1 
mM ethylenediaminetetraacetic acid (EDTA), pH 8.0 at 37 °C overnight. 
The supernatant was collected and the extraction repeated two more times. 
It was then combined and filtered through a 0.2 μm syringe filter. Butanol 
extractions were used to concentrate the RNA solution to 500 μl followed 
by addition of 10 μl of 25 mg/ml glycogen and 1 ml ethanol for an 
overnight precipitation at -80°C. The tRNA pellet was washed twice with 
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70% ethanol and precipitated. Purified tRNALeu was denatured at 80°C for 
1 min, followed by addition of 1 mM MgCl2 and quick-cooling on ice to 
re-fold. The concentration of tRNA was measured by absorbance at 260 
nm. 
4.2.7 Aminoacylation assays 
Leucylation of in vitro transcribed ymtRNALeu and EctRNALeu was 
carried out with 50 nM or 1 μM of the wild type and mutant proteins and 4 
μM tRNALeu. The aminoacylation reactions also contained 60 mM Tris (pH 
7.4), 10 mM MgCl2, 1 mM dithiothreitol (DTT), and 20 μM [3H]-leucine 
(152 Ci/mmol). The reactions were initiated with 4 mM ATP. Subsequently, 
5 μl aliquots were quenched on Whatman grade 3 filter pads (Kent, UK) 
that were pre-wet with 5 % TCA. The pads were then washed three times 
for 10 min in cold 5 % TCA, 10 min in cold 70 % ethanol followed by 
drying with ethyl ether (anhydrous). The radioactivity of the dried pads 
was quantitated using an LS 6000SC scintillation counter (Beckman). 
4.3 Results 
4.3.1 Substitutions at A293 in E. coli LeuRS do not alter yeast 
mitochondrial function. 
It has been shown that EcLeuRS, MtbLeuRS and hmLeuRS 
compensated for the absence of the endogenous ymLeuRS in its bi-
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functional roles protein synthesis and group I intron splicing (Houman et 
al., 2000; Sarkar et al., 2012). We further screened for molecular 
determinants that govern group I intron splicing in the non-splicing 
EcLeuRS. 
The CP1 domain is responsible for both amino acid editing (Betha et 
al., 2007; Lincecum et al., 2003; Mursinna et al., 2004; Mursinna et al., 
2001) and RNA splicing activity (Rho et al., 2002; Sarkar et al., 2012). A 
CP1 based key residue, A293, in EcLeuRS was identified to be important 
for rescue of alternate editing pathway (Williams & Martinis, 2006). It is a 
semi-conserved amino acid which occurs across various LeuRSs either as 
an alanine or a positively charged residue (Figure 4.1). However, in 
ymLeuRS there is very little homology within this region when compared 
to other LeuRSs. 
Mutants at the A293 position were also analyzed for their bi-functional 
roles in the null strains of yeast. We introduced positive and negative 
charged substitutions at the A293 position in EcLeuRS. The A293K, 
A293R and A293D LeuRS mutants were tested in complementation assays 
to determine their effect on yeast mitochondrial protein synthesis and 
intron splicing. All of these EcLeuRS mutants compensated for the dual 
roles of the endogenous ymLeuRS (Figure 4.2A). Nevertheless, in vitro 
leucylation of ymtRNALeu demonstrated that the A293D substitution had a 
significant decrease of aminoacylation activity when compared to the 
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A293K and A293R mutant enzymes which exhibited similar activity to the 
wild type enzyme (Figure 4.2B). 
 
 
 
 
Figure 4.2 Complementation and aminoacylation activities of 
EcLeuRS semi-conserved alanine mutants. A. Complementation of the 
yeast null strains by the A293K, A293R and A293D EcLeuRS mutants. 
Growth on glycerol media is due to mitochondrial function, which is 
indicated by red color (dark in the figure) on glucose media (due to an ade-
81 
 
2 mutation (Strathem, 1982)). B. Leucylation of ymtRNALeu by the A293 
mutant EcLeuRSs. Aminoacylation of ymtRNALeu was carried out with 50 
nM of the enzyme and 4 μM in vitro transcribed tRNA. The EcLeuRSs 
used in the assay were: wild type (■); A293K (+); A293R (□) and A293D 
(×).  This figure is cited from (Poruri, 2007). 
4.3.2 Low expression levels of EcLeuRS in yeast mitochondria 
fail to support splicing activity. 
A clone containing the EcLeuRS gene was isolated that failed to 
complement the HM410 yeast null strain that requires both of the LeuRS 
protein synthesis and splicing functions. DNA sequence determined that 
the upstream mitochondrial import sequence (Houman et al., 2000) was 
frame shifted due to the presence of a stop codon after the mitochondrial 
import sequence (Figure 4.3A). We hypothesized that the EcLeuRS was 
produced at reduced levels when this clone was allowed to express in the 
yeast mitochondria, but were unable to isolate the protein from 
mitochondrial extracts for quantitation. The frame shift clone is 
represented by EcLeuRS*. When tested in complementation assays 
involving the yeast null strains, EcLeuRS* complemented the intronless 
strain (HM402) but were unable to facilitate growth of the wild type 
(HM410) strain on glycerol media (Figure 4.3B). Thus EcLeuRS was 
expressed at amounts that were imported into the mitochondria that were 
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just sufficient enough to support protein synthesis activity, but not the 
alternate functions. 
Since the A293D EcLeuRS mutant had low levels of leucylation 
activity in vitro, we utilized the same mutant in the EcLeuRS* expression 
system to detect its effect on mitochondrial viability. When the A293 was 
mutated to aspartic acid (A293D*) and expressed from the EcLeuRS* 
clone, it failed to complement both the intron containing (HM410) and also 
the intronless (HM402) strain on glycerol media (Figure 4.3B). Thus, the 
mutant was unable to aid in mitochondrial protein synthesis at reduced 
levels of protein expression. 
We further tested the importance of this CP1-based semi-conserved site 
of EcLeuRS by introducing positively charged lysine and arginine at the 
A293 residue. The positively charged substitutions A293K and A293R that 
were hypothesized to be expressed at low levels from the EcLeuRS* clone 
rescued complementation activity in the strain that lacked mitochondrial 
introns showing that it could aid in protein synthesis. Surprisingly, these 
also complemented the wild type yeast null strain, suggesting that this site 
can adapt to support RNA splicing as well as protein synthesis. RNA 
analysis by northern hybridization revealed spliced B4-B5 exon products 
in the presence of the A293K and A293R mutant LeuRS enzymes but not 
for EcLeuRS* wild type or EcLeuRS* A293D mutant (Figure 4.3C). 
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Figure 4.3 Expression of reduced levels of EcLeuRS wild type and 
mutant proteins in yeast mitochondria. A. Mitochondrial import 
sequence of EcLeuRS* represented in grey shading. Black and white 
letters indicate alternate triplet codons. The stop codon is represented by 
an asterisk (*). The arrow represents the beginning of the EcLeuRS gene. 
B. Complementation activity of EcLeuRS mutants in yeast null strains. 
Growth on glycerol media indicates functional mitochondria, which is also 
represented by dark colored colony on glucose media (due to an ade-2 
mutation (Strathem, 1982)). C. Northern hybridization of yeast total 
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cellular RNA. RNA extracted from the yeast null strain HM410 cells 
expressing wild type EcLeuRS* and A293D, A293K and A293R mutant 
enzymes was separated on 1% formaldehyde agarose gel and hybridized 
with a probe that represented the B4-B5 exon junction.  This figure is 
cited from (Poruri, 2007). 
4.3.3 The A293 residue of EcLeuRS is splicing sensitive in 
vitro 
To confirm the in vivo complementation results, A293D, A293K and 
A293R EcLeuRS mutants were affinity-purified and tested in in vitro 
splicing assay. WT EcLeuRS was already tested in a previous publication 
and exhibited comparable splicing activity as WT ymLeuRS. Here the 
A293D mutant demonstrated decreased splicing activity compared with 
wild-type EcLeuRS, whereas A293K maintains the same activity (Figure 
4.4). A293R has significantly lower splicing activity than A293K, but still 
higher than A293D. These results are in accordance with the northern 
hybridization results in Figure 4.3C, in which A293D yielded no spliced 
exon, whereas one of the A293R duplicated results showed less amount of 
spliced exon compared with A293K. The kinetics of the splicing reactions 
is summarized in Table 4.2.  This figure is cited from (Poruri, 2007). 
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Figure 4.4 splicing activity of EcLeuRS mutants in vitro. Evaluation of 
in vitro bI4Δ1168 pre-RNA splicing with respect to (A & B) processing of 
substrate pre-RNA, (C & D) fraction of bI4 excised intron, and (E & F) 
fraction of the ligated B4-B5 exons is shown. Splicing reactions 
incorporated 1μM concentrations of substrate pre-RNA and 1μM LeuRS 
and were initiated with 1 mM guanosine. The E. coli LeuRSs used were: 
wild type (■); A293K (+); A293R (□) and A293D (×).  Error bars for each 
time point result from each reaction repeated in triplicate. 
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Table 4.2 Observed (kobs) values for bI4 intron splicinga 
EcLeuRS Pre-RNA B4-B5 bI4 intron 
 kobs × 10
-3 min-1 kobs × 10
-3 min-1 kobs × 10
-3 min-1 
WT  74 ± 16 29 ± 6 25 ± 5 
A293D  334 ± 111  444 ± 225  451 ± 235 
A293K  57 ± 11 20 ± 5 23 ± 5 
A293R 306 ± 86 32 ± 7  61 ± 11 
aStandard error is based on measurements that were repeated at least in 
triplicate. 
 
Circular dichroism (CD) was carried out to check whether the 
aminoacylation or splicing deficiencies in the mutants were caused by 
structural change. Figure 4.5 reveals that all of the mutations minimally 
affect secondary structure of the protein, as their CD spectra overlap with 
the wild-type LeuRS. Therefore, low splicing activity in A293R and 
splicing deficiency in A293D mutant are not caused by structural 
disruption. 
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Figure 4.5 CD spectra of the EcLeuRS wild-type and mutant proteins. 
Protein samples were prepared in 5 mM KPi, pH 7.5. The E. coli LeuRSs 
used were: wild type (■); A293K (+); A293R (□) and A293D (×). 
4.4 Discussion 
We have shown that when expression level is high, all of the mutants 
(A293D, A293K and A293R) as well as the wild-type EcLeuRS 
compensated for splicing function of yeast mitochondrial LeuRS in vivo. 
When expression level is low, only A293K and A293R but not A293D or 
WT EcLeuRS complemented for splicing. In in vitro splicing results and 
northern hybrid analysis, A293K has similarly high splicing activity as 
wild-type EcLeuRS, A293R has lower but still significant activity, and 
A293D has minimum activity. The results indicate that other characteristics 
instead of their own splicing activity reflected in the in vitro assay 
contribute to their in vivo compensation ability of the splicing deficient 
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yeast strain. One possibility is that the in vitro splicing assay was carried 
out using a truncated intron bI4Δ1168, and A293 site happens to interact 
with the truncated region, so that the splicing activity of the mutants were 
not completely reflected in the splicing assay. Another explanation is that 
positive charge on the A293 site dynamically influenced interaction 
between the bI4 intron and its other splicing partner, bI4 maturase, 
considering LeuRS, bI4-maturase and the bI4 intron have been found to 
form a complex. In another word, mutations on the A293 site might affect 
intron splicing indirectly through improving splicing activity of the bI4 
maturase.  
It was shown previously that A293 is also an editing sensitive site of 
EcLeuRS. Introduction of aspartic acid mutation on the A293 site (A293D) 
rescues post-transfer editing deficiency of the T252 mutant by presumably 
activating a pre-transfer editing pathway, whereas A293K and A293R 
failed to. In summary, A293D mutation enhances pre-transfer editing, 
while abolishing splicing activity of EcLeuRS. This coincides with 
previous reports that editing function and splicing function are in a “yin-
yang” balance in LeuRS. 
Apart from EcLeuRS, MtbLeuRS can also substitute ymLeuRS in 
intron splicing (Houman et al., 2000). Interestingly, the corresponding site 
of A293 of EcLeuRS on MtbLeuRS, R399, is also splicing sensitive (Poruri, 
2007). The alanine substitution (R399A) did not have any effect on 
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mitochondrial protein synthesis and RNA splicing. The introduction of 
negatively charged aspartic acid (R399D) resulted in loss of both functions, 
while the MtbLeuRS R399E mutant supported protein synthesis, but did 
not assist in bI4 intron splicing. These results demonstrate that either an 
alanine or an arginine on the conserved A293 (or R399) site of EcLeuRS 
(or MtbLeuRS) can support their splicing function, which coincides with 
the semi-conserveness of this site across various LeuRSs either as an 
alanine or a positively charged residue. This indicates that splicing function 
of these non-splicing LeuRSs is dependent on conserved features of LeuRS. 
However, splicing sensitive sites failed to be identified in the A293 
corresponding region of ymLeuRS (Poruri, 2007). In addition, the CP1 
domain of EcLeuRS where the Ala293 residue located failed to exhibit bI4 
intron splicing activity, in contrast to its counterpart in ymLeuRS. This 
indicates that at least on the CP1 domain, EcLeuRS and MtbLeuRS aid 
intron splicing in yeast mitochondria with a completely different 
mechanism than ymLeuRS, which might represent an alternative 
evolutionary pathway for LeuRS to acquire the splicing function that the 
nature happened not to choose. 
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Chapter 5. Leucyl-tRNA synthetase 
facilitates group I intron remodeling 
5.1 Introduction 
In yeast mitochondria, the bI4 and aI4α group I introns are located 
within the genes encoding cytochrome b (cob) and cytochrome oxidase α 
subunit (coxIα) (Slonimski et al., 1978). Splicing of these two introns is 
facilitated by nuclear-encoded mitochondrial leucyl-tRNA synthetase 
(LeuRS) and mitochondria-encoded bI4 maturase (Herbert et al., 1988; 
Labouesse, 1990; Labouesse et al., 1985). The LeuRS and bI4 maturase 
bind independently to the bI4 intron and stimulate RNA splicing (M. T. 
Boniecki et al., 2009; Rho & Martinis, 2000). 
Along with other group I introns, the bI4 and aI4α introns share a 
conserved catalytic core, which is comprised of two sets of coaxial helices 
P4-P6 and P3-P9 (Adams et al., 2004; Golden, Kim, & Chase, 2005; F. 
Guo, Gooding, & Cech, 2004; Michel & Westhof, 1990) (Figure 5.1A, B). 
Both introns also possess a long (>700 nucleotides) extended P8 loop insert, 
which is part of the open reading frame for the genes encoding bI4 
maturase and DNA aI4α endonuclease, respectively. The 31-nucleotide P6 
loop at the end of the bI4 intron P6 stem is distinct compared to the much 
smaller loop of the aI4α intron. The P5 helix of the bI4 intron contains two 
inserts that are missing in the aI4α intron. The first 21-nucleotide insert is 
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predicted to form a hairpin that has a long-range interaction with the P9 
loop. The second 120-nucleotide insert called “hj” is proposed to fold into 
an isolated domain and seems to be stabilized independently by a self-
contained long-distance interaction (M. T. Boniecki et al., 2009; Hsu, 
2006). 
Based on comparative analysis of bI4 and aI4α introns, deletion 
mutagenesis was carried out to construct minimum bI4 intron that is bound 
and processed in a LeuRS-dependent manner (M. T. Boniecki et al., 2009). 
A small derivative of the bI4 intron canonical core of just 380 nucleotides 
(bI4Δ1168) was generated, in which the P5 “hj” insertion is deleted and the 
P6 and P8 loop replaced with highly stable tetraloops (Jaeger, Michel, & 
Westhof, 1994; Murphy & Cech, 1994) (Figure 5.1C). This minimum bI4 
intron construct bI4Δ1168 has similar LeuRS-binding affinity as the full-
length intron and is stimulated for splicing by LeuRS in vitro (M. T. 
Boniecki et al., 2009). 
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Figure 5.1 Predicted secondary structures of the group I introns. The 
secondary structure of the bI4 intron (A) and aI4α intron (B) canonical core 
was based on previous predictions (M. T. Boniecki et al., 2009; Michel & 
Westhof, 1990). Solid bold lines indicate linear connectivities of the 
nucleic acid strand with arrowheads oriented in the 5’ to 3’ direction. The 
dashed lines represent proposed tertiary interactions. Arrows in the P1 and 
P9 domain show splice sites, where boxed nucleotides are paired regions. 
(C) bI4Δ1168 deletion mutant. The abbreviation TL indicates loops where 
a GAAA (P6 and P5) or GUAA (P8) tetraloop was introduced. 
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In addition to LeuRS and maturases, other group I intron splicing 
factors that have been extensively characterized include Mss116p in yeast 
mitochondria, tyrosyl-tRNA synthetase (TyrRS or CYT-18) and CYT-19 in 
Neurospora crasssa mitocohondria. The Mss116p and CYT-19 proteins are 
DEAD-box RNA helicases that facilitate folding and splicing of 
mitochondrial group I and group II introns, primarily by unwinding RNA 
duplexes to disrupt stable but inactive RNA structures in an ATP-dependent 
manner (Halls et al., 2007; S. Mohr et al., 2006; S. Mohr et al., 2002; Solem 
et al., 2006; Tijerina et al., 2006). 
CYT-18 recognizes highly conserved secondary and tertiary features 
of the catalytic core of the intron RNA, one of which is a transient P4-P6 
structure that is stabilized by CYT-18 in an early step in the group I intron 
folding process (Caprara, Lehnert, Lambowitz, & Westhof, 1996; Myers, 
Kuhla, Cusack, & Lambowitz, 2002; Myers et al., 1996; Webb, Jones, & 
Dodd, 2001). The solved crystalized structure combined with biochemical 
data suggest that CYT-18 does not rely on its tRNA binding face. Rather, 
CYT-18 uses a distinct intron-binding surface which is absent from non-
splicing bacterial TyrRSs (Paukstelis et al., 2008). 
It is known that LeuRS alone can facilitate splicing of the bI4 intron 
in the absence of the other splicing factor bI4-maturase (M. T. Boniecki et 
al., 2009), and the editing domain and the C-terminal domain of LeuRS are 
involved in its splicing activity (Hsu et al., 2006; Rho et al., 2002; Sarkar 
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et al., 2012). The mechanism of splicing stimulation by yeast 
mitochondrial LeuRS (ymLeuRS) still needs to be further elucidated. 
Herein, we identified novel LeuRS-dependent annealing of P6 duplex 
mimetics. We hypothesized that LeuRS facilitates bI4 intron folding to 
stimulate splicing. 
5.2 Experimental methods 
5.2.1 Plasmid construction and mutagenesis 
Plasmids in Table 5.1 and Table 5.2 were used to transcribe RNAs for 
in vitro assays, and to express wild-type and mutant proteins, respectively. 
Table 5.1 Plasmids used for in vitro transcription of RNAs 
RNA encoded Plasmid name Reference 
bI4Δ1168 pM96Δhj1-3 (M. T. Boniecki et al., 2009) 
ymtRNALeu UAA pGP1-2 
Gift from Dr. T. Palmer, University of East 
Anglia, UK 
 
Table 5.2 Plasmids used for protein expression 
Protein encoded Plasmid name Reference 
ymLeuRS p14MB-ymLeuRS-WT (Rho & Martinis, 2000) 
ymLeuRSΔC p32MB-ymLeuRS-∆C (Hsu et al., 2006) 
ymLeuRSΔC5 p32MB-ymLeuRS-∆C5 (Hsu et al., 2006) 
ymLeuRSΔCP1 p32MB-ymLeuRS-dCP1(2A) (M. T. Boniecki et al., 2008) 
ymLeuRS-CP1 p14MB-ymCP1-N-C (Sarkar et al., 2012) 
ymLeuRS-CP1-βext p14MB-ymCP1+N+C (Sarkar et al., 2012) 
EcLeuRS p14MB-EcLeuRS-WT (M.T. Boniecki, 2007) 
Human mt (hm) 
LeuRS 
P32MB-hmLeuRS-WT (M.T. Boniecki, 2007) 
EcIleRS p14MB-EcIleRS-WT (M.T. Boniecki, 2007) 
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5.2.2 Construction of tRNA genes 
The genes for the mutants of yeast mitochondrial tRNALeu UAA 
(ymtRNALeu UAA) and E. coli tRNA
Leu
UAA (EctRNA
Leu 
UAA) with an 
upstream T7 RNA polymerase promoter and a downstream BstNI 
restriction site were constructed by ligation of seven or eight overlapping 
DNA oligonucleotides (Table 5.3). Each DNA oligonucleotide at 1 μM 
concentration was first phosphorylated with 1.7 μM [γ-32P]-ATP 
(6000Ci/mmol 10mCi/ml), 10 U T4 polynucleotide kinase (New England 
Biolabs Inc., Beverly, MA) in commercial buffer for 2 hrs. The 
phosphorylation reaction was subsequently inactivated at 65 °C for 10 min. 
All seven oligonucleotides were directly mixed without addition of water 
or buffer and annealed by being heated in a 95 °C water bath for 3 min and 
then gradually cooled down to room temperature still in the water bath for 
approximately 45 min, to form the annealed insert with overhangs suitable 
for cloning into the EcoRI and PstI restriction sites. 
The plasmid pUC18 (4 μg) was digested with 80 U EcoRI and PstI in 
commercial buffer, followed by purification using a QIAquick PCR 
purification kit. A 20 μl ligation reaction containing 0.02 μM digested 
pUC18, 0.1 μM insert and 400 U T4 ligase in commercial buffer was 
incubated for 30 min at room temperature. The ligase was inactivated at 
65 °C for 20 min. 
The 2 μl ligation mixture was added to 50 μl DH5α competent E. 
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coli cells for transformation using heat shock. The transformed cells were 
cultured overnight on Luria broth (LB) plate containing 100 μg/ml 
ampicillin antibiotic. To select the colonies that contain the tRNA genes, 
ten colonies were chosen and screened by colony PCR reactions for each 
tRNA gene. Colony suspensions were prepared by resuspending individual 
colonies with sterile pipette tip in 50 μl water. The tips were also dropped 
into 3 ml LB media individually, which were cultured overnight to create 
stocks for each colony. 
The 25 μl colony PCR reaction contained 5 μl of the colony 
suspension, 200 μM dNTPs, 2 μM primers (seq3A: 5’-
GCTCGCCGCAGCCGAACGACCGAGCG-3’, FOR88: 5’- 
GCTGGCGAAAGGGGGATGTGCTG-3’), 250 μg/ml bovine serum 
albumin (BSA), 0.5 U Vent polymerase (New England Biolabs Inc., 
Beverly, MA) in commercial buffer. Under the following conditions, 30 
cycles of PCR were carried out: 94 °C for 1 min, 55 °C for 30 sec, and 
72 °C for 40 sec. The PCR products were digested with 10 U BstNI at 65 °C 
for 2 hr and assessed by electrophoresis, where a band ~ 500 bp represents 
successful construction of the tRNA gene. For colonies that contained the 
gene encoding the respective tRNA, plasmids were extracted from the 
corresponding overnight cultures using the Qiagen Spin Miniprep kit. The 
tRNA gene sequences in the plasmids were confirmed using DNA 
sequencing (UIUC Core Sequencing Facility, Urbana, IL). 
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Table 5.3 DNA oligonucleotides used for construction of tRNA genes 
tRNA DNA ligonucleotides 
ymtRNALeu-EcVL 
1 5’-CTATAGCTATTTTGGTGGAATT-3’ 
2 5’-GGTAGACACGATACTCTTAAGATGTAT-3’ 
3 5’-CGGCGTTCGCGCTGTGAA-3’ 
4 5’-GGTTCAAGTCCTTTAA-3’ 
5 5’-ATAGCACCAGGAGACCCTGCA-3’ 
6 5’-GTGTCTACCAATTCCACCAAAATAGC-3’ 
7 5’-GAACCTTCACAGCGCGAACGCCGATACATCTTAA 
GAGTATC-3’ 
8 5’-GGGTCGCCTGGTGCTATTTAAAGGACTT-3’ 
EctRNALeu-ymVL 
1 5’-CTATAGCCCGGATGGTGGAATC-3’ 
2 5’-GGTAGACACAAGGGATTTAAAATCCCTT-3’ 
3 5’-ACTTTACAGTATGCG-3’ 
4 5’-GGGTACCAGGCTGCAG-3’ 
5 5’-CGGGTACCAGGAGACCCTGCA-3’ 
6 5’-GAACCCGCATACTGTAAAGTAAGGGATTTTAAAT 
CCCTT-3’ 
7 5’-CGGGCCTACCACCTTAGCCATCTGTG-3’ 
5.2.3 Transcription of tRNAs in vitro 
 The in vitro transcription of the tRNAs used in this study was carried 
out as described in Chapter 2. The primers used in preparation of the 
templates via PCR amplification are seq3A and FOR88. 
5.2.4 Protein expression and purification 
Plasmids expressing the desired proteins were used to transform E. 
coli BL21 (DE3) codon plus strain (Agilent Technologies, Santa Clara, 
CA). Bacteria cultures were grown at 37 °C and induced with 1 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) for protein expression at 
room temperature overnight. The N-terminal six-histidine-tagged fusion 
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protein was purified and quantified as described in Chapter 2. Purified 
EcLeuRS and human mitochondrial LeuRS (hmLeuRS) proteins are gifts 
from A. Banerjee and Dr. K. Poruri, respectively. 
5.2.5 Oligonucleotides radioactive labeling and in vitro 
annealing assay 
The synthesized RNA or DNA oligonucleotides (Integrated DNA 
Technologies Corp., Coralville, Iowa) used for in vitro annealing assay 
were phosphorylated at the following reaction condition: 1 μM oligo, 1.7 
μM [γ-32P]-ATP (6000Ci/mmol, 10mCi/ml) (Pelkin Elmer, Waltham, MA) 
and 10 U T4 polynucleotide kinase (New England Biolabs Inc., Beverly, 
MA) in commercial buffer. All radioactive RNA preparations were purified 
on Chroma Spin + TE-10 columns (Clontech Laboratories, Inc., Mountain 
View, CA). 
An RNA annealing reaction contained equimolar of the two 
oligonucleotide strands (typically 0.1 nM), with one oligonucleotide end-
labeled with [32P]. A final concentration 20 nM LeuRS was added in 1× 
annealing buffer (40 mM Tris pH 7.5, 50 mM KCl, 0.5 mM MgCl2, 2 mM 
DTT and 0.01% NP-40) and incubated for 30 min at room temperature. 
The reaction was stopped by adding an equivalent volume of 1% (w/v) 
SDS, 50 mM EDTA, 0.1% (w/v) xylene cyanol, 0.1% (w/v) bromophenol 
blue, and 20% glycerol and the sample placed on ice. 
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The annealing reaction was analyzed on a 15% native acrylamide gel 
at 200 V for 80 min in 1× TBE buffer at 4 °C. The gel was dried with a 
vacuum gel dryer (Bio-Rad Laboratories, Hercules, CA) and 
phosphorimaged using a FUJIFILM BAS Cassette 2040 (FUJIFILM 
Medical Systems, Stanford, CT). Products were visualized by scanning the 
images using a STORM 840 Molecular Dynamics scanner (Amersham 
Biosciences Corp., Piscataway, NJ). Specific radioactive bands were 
quantified using ImageQuant software. Bands representing the annealed 
duplex and single-strand oligonucleotide were normalized for each time 
point by determining the fraction of each, relative to the sum intensity of 
the two bands. In addition, background was subtracted based on the zero 
time point. Extent of reaction (product/total bands in lane) was calculated 
using GraphPad Prism 5 via its single exponential function. 
5.3 Results 
5.3.1 LeuRS facilitates annealing of RNA duplexes. 
Previously deletion analysis identified a minimized bI4 intron that 
was dependent on LeuRS for splicing. It is possible that LeuRS, similar to 
CYT-18, binds and stabilize conformation of the bI4 intron. We 
hypothesized that LeuRS might facilitate accurate folding of the bI4 intron. 
Significantly, measurements that defined LeuRS-dependent splicing 
indicated the level of completely folded bI4 intron was greatly increased in 
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the presence of LeuRS (M.T. Boniecki, 2007). We wondered if LeuRS 
could facilitate annealing of the bI4 intron core. Core regions of minimized 
bI4 intron (bI4Δ1168) (Figure 5.1C) was shown to directly interact with 
LeuRS in preliminary RNA footprinting experiment (M.T. Boniecki, 2007). 
It was hypothesized that LeuRS stabilized these core regions. 
A P6 stem-loop mimetic RNA duplex P6n (Figure 5.2A) was designed 
to probe LeuRS-dependent duplex annealing activity. In conditions that 
facilitate bI4 intron splicing in vitro (M. T. Boniecki et al., 2009), 
complementary oligonucleotides were introduced at low 0.1 nM 
concentration to slow protein-independent annealing. Importantly, in the 
presence of affinity purified LeuRS, nearly all the single-strand oligos 
annealed into P6n duplexes. In contrast, in the absence of LeuRS, about 1% 
oligos formed duplexes (Figure 5.2). This result suggests that LeuRS 
facilitates RNA duplex annealing, which was not boosted by addition of 
ATP-Mg2+ (Figure 5.2C). 
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Figure 5.2 Yeast mitochondrial LeuRS facilitates annealing of RNA 
duplexes.  A. Predicted secondary structure of the bI4 intron (M. T. 
Boniecki et al., 2009). The P6-P6a-P6b region is boxed with the P6n 
mimetic duplex shown on the right. B. Gel shift assay on a native 15% 
acrylamide gel displays 1 nM [32P]-labeled 3’ strand (lower band) annealed 
to 10 nM unlabeled 5’ strand to form the P6n duplex (upper band) in the 
absence (□) or presence (■) of 100nM LeuRS in 1 × annealing buffer (40 
mM Tris pH 7.5, 50 mM KCl, 0.5 mM MgCl2, 2 mM DTT and 0.01% NP-
40).  C. Time course of P6n duplex formation in the absence or presence 
of 100 nM LeuRS or 2 mM ATP-Mg2+.  Error bars are the result of 
experiments repeated triplicate. 
5.3.2 Magnesium inhibits LeuRS-dependent duplex annealing 
Cations, especially Mg2+, are typically incorporated into in vitro 
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reactions to shield the negatively charged phosphate backbone and promote 
folding of RNA. Although Mg2+ is required for group I intron splicing, 
concentrations that were higher than 5 mM impede LeuRS-dependent 
bI4Δ1168 splicing (M. T. Boniecki et al., 2009). We tested different 
concentrations of Mg2+ to determine optimum Mg2+ concentrations for 
LeuRS-dependent in vitro annealing of the P6n duplex (Figure 5.3). 
Similar to LeuRS-dependent splicing of the bI4 intron, increasing 
concentration of Mg2+ hindered annealing of the P6n duplex. An optimal 
concentration of 0.5 mM Mg2+ promoted LeuRS-dependent annealing, 
which is similar to LeuRS-dependent splicing in vitro. In contrast, RNA 
annealing of the P6n duplex was enhanced in the presence of Mg2+. 
 
Figure 5.3 Magnesium inhibits LeuRS-dependent annealing.  A. In 
the absence of LeuRS, P6n duplex annealing increased in the presence of 
20 mM Mg2+.  Error bars are the result of experiments repeated in 
triplicate. B. Annealing curves of LeuRS-dependent P6n duplex annealing 
in the presence of 0.5 mM (□), 1 mM (▼) and 20 mM Mg2+ (■). 
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5.3.3 Yeast mitochondrial LeuRS has evolved to anneal RNA 
duplexes. 
Our lab has previously shown that in addition to ymLeuRS, 
prokaryote and human LeuRSs also suppress splicing defects when the bI4 
maturase is inactivated (Houman et al., 2000; Sarkar et al., 2012). This 
suggests that LeuRS in general contain an ancient core that is responsible 
for splicing. Nevertheless, the ymLeuRS is optimized for efficient splicing. 
For example, the LeuRS from E. coli exhibits lower in vitro splicing 
activity compared with ymLeuRS (Sarkar et al., 2012). 
In order to determine whether the dependence of bI4 intron P6 region 
annealing is unique to ymLeuRS, we tested other proteins in the P6n duplex 
annealing assay. Non-LeuRS proteins, including BSA as well as E. coli 
isoleucyl-tRNA synthetase (EcIleRS) failed to significantly stimulate 
annealing (Figure 5.4A). In addition, LeuRSs from human cytoplasmic 
(hcLeuRS) and E. coli (EcLeuRS) exhibited very little annealing activity 
of the P6n helix (Figure 5.4B). The weak annealing promotion activity of 
EcLeuRS corresponds with its low bI4 intron splicing activity (Sarkar et 
al., 2012). It is worth mentioning that the buffer of the annealing reaction 
is compatible with the aminoacylation activity of the above AARSs (Sarkar 
et al., 2012), which rules out the possibility that protein folding defect 
accounts for their lower annealing stimulation activity. Interestingly, only 
yeast cytoplasmic LeuRS (ycLeuRS) showed a significant P6n duplex 
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annealing activity, although still lower than its yeast mitochondrial 
counterpart (Figure 5.4B). 
We hypothesized that the bulged region on the P6 stem-loop might 
serve as a sequence specific features for recognition by LeuRS. We 
designed another P6 stem-loop mimetic duplex P6-33 that eliminates the 
bulge by creating a series of base-pairs (Figure 5.4C). Interestingly, the 
annealing activity of the P6-33 duplex was increased in the presence of 
EcIleRS and EcLeuRS of comparable levels to that promoted by ymLeuRS. 
The activity in hcLeuRS was also increased, albeit still at a lower level 
(Figure 5.4C). These results demonstrate that ymLeuRS has uniquely 
adapted to facilitate duplex annealing of a core region of the bI4 intron. We 
propose that ymLeuRS has specifically evolved to recognize and promote 
folding of critical bulge in the bI4 intron P6 stem-loop. 
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Figure 5.4 Yeast mitochondrial LeuRS has evolved to anneal RNA 
duplexes.  A. Annealing of P6n duplex by ymLeuRS, E. coli IleRS 
(EcIleRS) and bovine serum albumin (BSA). Annealing reactions 
contained 1 nM [32P]-labeled 3’ strand and 10 nM unlabeled 5’ strand of 
the P6n duplex in the presence of 100 nM respective proteins in 1× 
annealing buffer. All of the annealing reactions using the P6n duplex were 
carried out in this condition. B. Annealing of P6n duplex by ymLeuRS, 
yeast cytoplasmic LeuRS (ycLeuRS), human cytoplasmic LeuRS 
(hcLeuRS), E. coli LeuRS (EcLeuRS). C. Annealing of P6-33 duplex by 
ymLeuRS, EcIleRS, EcLeuRS, hcLeuRS. Annealing reactions contained 
0.1 nM [32P]-labeled 3’ strand and 0.1 nM unlabeled 5’ strand of the P6-33 
duplex in the presence of 20 nM respective proteins in 1× annealing buffer. 
All of the annealing reactions using the P6-33 duplex were carried out in 
this condition.  Symbols are : (▽), BSA; (■), ymLeuRS; (△), EcIleRS ; 
(▲), ycLeuRS; (◇), hcLeuRS; (○), EcLeuRS.  Error bars are the result 
of experiments repeated triplicate. 
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Deletion mutants of the ymLeuRS were then tested to identify specific 
domains of LeuRS that contribute to its annealing activity. Similar to other 
synthetases, N-terminal canonical core of LeuRS is appended to a second 
domain that is less conserved (Burbaum & Schimmel, 1991; Martinis & 
Schimmel, 1996). However, unlike other AARSs, this LeuRS domain does 
not interact with the anticodon for cognate tRNA recognition (Asahara et 
al., 1993; Larkin et al., 2002). Rather, a C-terminal extension of about 60 
amino acids folds into a unique domain (CTD) that is tethered via a flexible 
linker and interacts with the corner of the L-shaped tRNA (Figure 5.5A) 
(Palencia et al., 2012; M. J. Yaremchuk, 2005). In the absence of tRNALeu, 
this small unique CTD is disordered in the LeuRS apo-crystal structure (A. 
Yaremchuk, Cusack, & Tukalo, 2000). 
Deletion of the CTD has been shown to abolish aminoacylation of 
LeuRS (Fukunaga, Ishitani, Nureki, & Yokoyama, 2005; Tukalo et al., 
2005; Zheng et al., 2004). In addition, deletion of the last five amino acid 
or the entire CTD abolished LeuRS suppression activity that rescues 
splicing activity of an inactive bI4 maturase (Houman et al., 2000; G. Y. Li 
et al., 1996). It was later confirmed that the five amino acid C-terminal 
deletion of LeuRS failed to stimulate bI4 intron splicing in vitro, although 
it can form a ternary complex with the intron and the bI4 maturase splicing 
partner (Hsu et al., 2006). Collectively, these results support than LeuRS 
CTD is important to intron splicing. 
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Since CTD is involved in bI4 intron splicing activity of LeuRS, we 
also hypothesized that it might participate in LeuRS-dependent RNA 
duplex annealing. Two deletion mutants of LeuRS were constructed (Hsu 
et al., 2006) and affinity-purified. One has the last five amino acid of the 
C-terminus truncated (LeuRSΔC5), while the other has the entire C-
terminus deleted (LeuRSΔC). Deletion of the five terminal residues or the 
entire C-terminal lowered annealing of the P6n duplex compared with full-
length LeuRS (Figure 5.5B). Since deletions of the CTD failed to 
completely abolish LeuRS-dependent annealing, it is likely that the LeuRS 
main body contributes to the remaining moderate annealing activity. 
In contrast to the P6n duplex, for the P6-33 duplex, LeuRSΔC5 
maintains comparable annealing activity as the full-length LeuRS. 
Surprisingly, LeuRSΔC annealed the P6-33 duplex with an even faster kobs 
than the wild-type LeuRS (Figure 5.5C). The high LeuRSΔC and 
LeuRSΔC5-dependent annealing activity again suggests that other regions 
of LeuRS also contribute to duplex annealing. 
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Figure 5.5 The C-terminal domain of LeuRS stimulates RNA duplex 
annealing. A. Structure of E. coli LeuRS-tRNALeu complex. The C-
teriminal domain of LeuRS, tRNALeu and its variable arm are colored 
orange, grey and green respectively. Annealing of the P6n (B) and the P6-
33 (C) duplex by full-length LeuRS, LeuRSΔC5 and LeuRSΔC.  
Symbols are: (■), full-length LeuRS ; (▲), LeuRSΔC5; (◆), LeuRSΔC; 
(▲), LeuRSΔC5; (□), no protein.  Error bars are the result of experiments 
repeated triplicate. 
 
The connective polypeptide 1 (CP1) domain of LeuRS is a 170-amino 
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acid insertion that splits the ATP binding Rossmann-fold that comprises 
aminoacylation active site of class I AARSs, folds discretely into a separate 
domain and is connected to the rest of the enzyme via two flexible β-strands 
(Figure 5.6A). Although the LeuRS CP1 domain is best known for its role 
in editing misacylated tRNALeu, it has been found to play a role in group I 
intron splicing. Splicing sensitive sites were identified within the CP1 
domain and its connecting β strands (Figure 5.6A). We have also shown 
that the isolated CP1 domain from ymLeuRS is sufficient in performing 
bI4 intron RNA splicing in vivo and in vitro (Rho et al., 2002; Sarkar et al., 
2012). 
Because the CP1 domain can stimulate bI4 intron splicing, we also 
hypothesized that it participates in LeuRS-dependent duplex annealing. 
Moreover, a LeuRS mutant that has the entire CP1 domain deleted 
(ymΔCP1) significantly enhances annealing activity compared with full-
length ymLeuRS (Figure 5.6C). On the other hand, the isolated ymLeuRS 
CP1 domain (ymCP1-βext and ymCP1-β) failed to stimulate P6n duplex 
annealing. We also tested a deletion of the CP1 domain for EcLeuRS, 
which also boosted its annealing activity (Figure 5.6D). The results support 
that the CP1 domain is not involved in RNA annealing activity of LeuRS, 
and may even impede it. 
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Figure 5.6 Deletion of the CP1 domain stimulates annealing activity of 
LeuRS. A. Homology model of ymLeuRS based on E. coli LeuRS (PDB 
accession code: 4AQ7) (Palencia et al., 2012). The CP1 domain is colored 
in blue, and splicing sensitive sites are in orange. B. Multiple sequence 
alignment of LeuRS CP1 domain and flanking regions containing both the 
N- and C-terminal β-strand linkers and extensions. The CP1 domain, β-
strand linkers, and β-strand extensions are shown in blue, red, and green, 
respectively. Bracketed numbers indicate the number of amino acids within 
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a peptide insert. The EcLeuRS A293 residue, which is absent in ymLeuRS, 
is highlighted in orange, and the corresponding peptide indicated by an 
orange line. Each of the yeast mitochondrial CP1 domain constructs is 
indicated at the top of the figure as follows: CP1 (Ile-260 to Glu-431), CP1-
β (Trp-238 to Leu-442), and CP1-βext (Lys-232 to Tyr-452). The N- and 
C-terminal ends of the CP1-βext construct are also indicated in the 
homology model. Scm, S. cerevisiae mitochondrial; Ec, Escherichia coli; 
Mt, M. tuberculosis. C. Annealing of the P6n duplex in the presence of 
wild-type (ymWT) or the following mutant constructs of ymLeuRS: 
ymΔCP1 with CP1 (Ile-260 to Glu-431) deleted, ymCP1β-ext, ymCP1. D. 
Annealing of the P6n duplex in the presence of wild-type (EcWT) or a 
mutant of EcLeuRS that deletes CP1 (Ala-230 to Gly-407) (EcΔCP1).  
Symbols are: (■), ymWT; (▲), ymΔCP1; (△), ymCP1β-ext; (▽), ymCP1; 
(●), EcWT; (■), EcΔCP1. Error bars are the result of experiments repeated 
triplicate. 
5.3.4 Cognate tRNA competes with RNA duplex for LeuRS-
dependent annealing. 
Because LeuRS relied on its CTD for annealing, and the CTD 
interacts with the corner of tRNA for aminoacylation, we wondered if 
tRNA would inhibit the enzyme RNA annealing activity. When 1 μM 
excess ymtRNALeu was added to the P6n duplex annealing reaction in the 
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presence of LeuRS, LeuRS-dependent annealing was abolished (Figure 
5.7A). The apparent KI of ymtRNA
Leu was determined to be 4.6 ± 0.4 nM 
(Table 5.4). In contrast, EctRNALeu didn’t inhibit LeuRS-dependent 
annealing under the same concentration as ymtRNALeu (Table 5.4). Thus, 
we hypothesized that binding the bI4 intron to ymLeuRS overlaps with the 
cognate ymtRNALeu in specific ways to facilitate P6n duplex annealing. 
Since we have shown that LeuRS CTD is involved in facilitating RNA 
duplex annealing, also given that the C-terminal interacts with the tRNALeu 
variable arm (Palencia et al., 2012), we hypothesized that the binding sites 
that interact with tRNALeu variable arm on the LeuRS C-terminal also 
interact with the annealed RNA duplex. To test that hypothesis, we 
designed two chimeric tRNAs in which we swapped the variable arms. The 
ymtRNALeu-EcVL chimera has the ymtRNALeu backbone with the variable 
stem-loop from EctRNALeu, and the EctRNALeu -ymVL has the EctRNALeu 
backbone with the variable stem-loop from ymtRNALeu (Figure 5.7B). 
Swap of the The EctRNALeu variable arm increased the apparent KI of 
ymtRNALeu by 30 fold to 120 ± 27 nM (Table 5.4). This suggests that the 
variable stem-loop plays a major role in the inhibition of cognate tRNA of 
LeuRS-dependent annealing. Introduction of the variable arm from 
ymtRNALeu increased inhibition of EctRNALeu in LeuRS-dependent 
annealing with a KI of 62 ± 10 nM (Table 5.4). These results emphasized 
that the tRNA inhibition of RNA annealing is largely influenced by the 
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variable arm. 
Table 5.4 Apparent kinetics of tRNA inhibition of P6n annealing 
Standard error is based on measurements that were repeated triplicatea 
tRNA KIapp [nM]a 
ymtRNALeu  4.6 ± 0.4 
ymtRNALeu-EcVL 120 ± 27 
EctRNALeu NDb 
EctRNALeu-ymVL  62 ± 10 
bNot determined because no annealing inhibition observed 
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Figure 5.7 Yeast mitochondrial tRNALeu competes with RNA duplex 
for LeuRS-dependent annealing. A. LeuRS-dependent P6n duplex 
annealing in the presence (□) or absence (■) of 1 μM ymtRNALeu. B. The 
wild-type and chimeric tRNAs used to compete with the duplex in LeuRS-
dependent annealing. ymtRNALeu-EcVL chimera: ymtRNALeu backbone 
with the variable stem-loop from EctRNALeu, EctRNALeu-ymVL chimera: 
EctRNALeu backbone with the variable stem-loop from ymtRNALeu.  
Error bars are the result of experiments repeated triplicate. 
 
Because the P6n duplex and ymtRNALeu variable arm appear to share 
binding sites on LeuRS, we sought to identify a region on the P6 stem-loop 
of bI4 intron that resembles the tRNALeu variable arm. A three-base-pair 
region on the P6 stem was identified that matches the ymtRNALeu variable 
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stem (Figure 5.8A). We designed a P6n duplex mutant (P6n-tMU) which 
has this three-base-pair swapped to perturb its local structural recognition 
elements, while preserving its stability (Figure 5.8A). As would be 
expected based on our results with the P6n duplex, in the absence of LeuRS, 
P6n-tMU duplex failed to anneal. In the presence of LeuRS, annealing of 
P6n-tMU was stimulated, but at much less efficiency than the P6n duplex 
(Figure 5.8B). The result suggests that LeuRS specifically recognizes the 
P6n duplex via an overlapping region on the protein that interacts with the 
tRNA variable arm. 
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Figure 5.8 The ymtRNALeu-variable-stem-like region on the P6 stem is 
important for LeuRS recognition. A. Sequence similarity between the P6 
stem and ymtRNALeu variable stem. Boxed are the three base pairs in the 
ymtRNALeu-variable-stem-like region that are reversed in P6-tMU. B. The 
P6n-tMU shows decreased LeuRS-dependent annealing activity compared 
with P6n. Symbols are: LeuRS-dependent P6n (■) and P6n-tMU (●) 
annealing; P6n-tMU annealing in the absence of LeuRS (○).  Error bars 
are the result of experiments repeated triplicate. 
5.3.5 Duplex overhangs enhance LeuRS-dependent annealing 
We used the P6n and P6-33 duplexes as the template to design several 
duplexes (Figure 5.11). Similar to tRNA identity, we hypothesized that 
LeuRS recognized specific sequence such as length and overhang 
dependency. We first tested the P6n native helix and reduced its length. 
This resulted in the design of P6n3’13, P6n5’13, P6ns, all of which failed to 
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anneal in a LeuRS-dependent way (Figure 5.9). Since no duplex formation 
was detected, the data is not shown. 
The P6-33 helix was used as a template to design P6-203’13 and P6-
205’13 and P6-20. In contrast, annealing of P6-203’13 and P6-205’13 was 
stimulated to a similar level as P6-33. Moreover, annealing of the blunt-
ended P6-20 was not increased by LeuRS (Figure. 5.9). The above results 
suggests that LeuRS is not able to anneal duplexes which cannot self-
anneal (P6n3’13, P6n5’13 and P6ns cannot anneal on their own even at high 
concentration using heat-up-cool-down annealing method). In another 
word, a base-pair number threshold exists for duplexes to be recognized by 
LeuRS. In addition, the blunt-ended P6-20 not recognized by LeuRS 
indicates that overhangs are critical for LeuRS recognition. 
We then further investigate the duplex length and overhang 
dependency for the P6-33 annealing stimulated by LeuRS. We designed 
duplexes with different lengths and overhangs originated from P6-33 upper 
stem region (Figure. S1). From the LeuRS-dependent annealing assay 
results (Figure 5.9), we can see that there is no stringent duplex length 
dependency in LeuRS-stimulated annealing. For example, annealing of P6-
195’1 is worse than P6-185’2 in the presence of LeuRS, although the former 
has a longer 5’ strand. Nevertheless, we observed LeuRS didn’t stimulate 
annealing of duplexes less than 18 base-pairs. 
Overhangs of nucleic acid strands are often critical to RNA helices 
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that assist annealing (Müller et al., 2001; Yang & Jankowsky, 2005). As 
such, we designed a series of P6-33 constructs to introduce 5’ and 3’ 
overhangs. Results show that annealing of duplexes with longer overhangs 
was promoted better by LeuRS. For example, the best ones are P6-33, P6-
335’13 and P6-333’13, which has the longest 13 nucleotide overhang; the 
worst one is the blunt-ended P6-20 (Figure 5.9B). Take P6-185’2, P6-195’1 
and P6-20 for another example, as the overhang length on the 5’ strand 
ranges from 2 to 0, duplex annealing in the presence of LeuRS also 
sequentially decreases from around 60% to none (Figure 5.9C). 
Moreover, we found that the overhang on the 5’ strand is more prone 
to LeuRS-dependent annealing than if the overhang is on the 3’ strand. The 
P6-19 UP5’1, P6-185’2 and P6-195’1 duplexes showed significant activity of 
LeuRS-dependent annealing (Figure 5.9C). All of them have 
corresponding duplexes designed with the overhang at the same length on 
the 3’ strand (Figure 5.9D). No duplex formation was observed in the 
absence or presence of those duplexes. Also, the P6-193’14 duplex which 
has a 3’ overhang has very little LeuRS-dependent annealing activity, 
similar to the blunt-end P6-20 (Figure 5.9B). Nevertheless, it appears that 
the number of base-pairs can mask the overhang location bias, as P6-205’13 
and P6-203’13 have similarly high LeuRS-dependent annealing activity. 
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Figure 5.9 Duplex overhangs enhance LeuRS-dependent annealing. A. 
Duplexes used to test overhang effect on LeuRS-dependent annealing. The 
bI4 intron P6 stem-loop is shown on the top left as reference. Duplexes 
colored in grey failed to show significant increase in annealing in the 
presence of 100 nM LeuRS. B, C, D. All of the curves shown are reactions 
that carried out in the presence of 100 nM LeuRS. Symbols are: (▼), P6-
33; (●), P6-205’13; (■), P6-203’13; (◆), P6-195’1UP; (▲), P6-185’2; (□), P6-
195’1; (○), P6-20.   Error bars are the result of experiments repeated 
triplicate. 
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5.3.6 The LeuRS-dependent P6-33 duplex annealing 
specificity 
We also asked whether LeuRS-dependent duplex annealing is specific 
to RNA. We designed DNA and RNA-DNA hybrid versions of the P6n and 
P6-33 duplexes. No annealing was observed in the presence or absence of 
LeuRS for the P6n DNA and RNA-DNA hybrid duplexes, thus the data is 
not shown. However, P6-33 duplex annealing of the 5’ DNA and the 3’ 
RNA strands was promoted by LeuRS. In contrast, annealing of the 3’ DNA 
and 5’ RNA wasn’t (Fig. 5.10). These results support that LeuRS binds the 
5’ RNA strand more directly. 
 
Figure 5.10 The LeuRS-dependent P6-33 duplex annealing specificity. 
Symbols are: (▼), 5’ RNA-3’ RNA; (×), 5’ DNA-3’ RNA; (△), 5’ RNA-
3’ DNA; (▽), 5’ DNA-3’ DNA.  Error bars are the result of experiments 
repeated triplicate. 
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Figure 5.11 
 
Figure 5.11 P6-stem mimetics. Duplexes colored grey don’t show 
significantly improved annealing in the presence of LeuRS. Boxed are the 
base pairs that are reversed. 
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Figure 5.11 (continued) 
 
Figure 5.11 P6-stem mimetics (continued). Duplexes colored grey don’t 
show significantly improved annealing in the presence of LeuRS. Boxed 
are the base pairs that are reversed. 
5.4 Discussion 
Group I introns use RNA-catalyzed splicing mechanisms (Cech, 
1990), but require protein splicing factors in vivo to fold into catalytically 
active structures. The group I intron splicing factors characterized so far 
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can be divided into three groups (Herschlag, 1995; Rajkowitsch et al., 
2007). The first group specifically binds to the intron, inducing the 
formation of the catalytically active RNA structure. Alternatively, the 
second group promotes splicing by capturing the native structure. In some 
cases, group I introns reply on a combination of the two mechanisms. An 
example of the second group is the CYT-18 in N. crassa mitochondria, 
which binds across one face of the coaxially stacked P4-P6 helix and also 
makes contacts with P3-P9 helix (Paukstelis et al., 2008). The group I 
intron P4-P6 and P3-P9 helices form its conserved catalytic core (Adams 
et al., 2004; Golden et al., 2005; F. Guo et al., 2004; Michel & Westhof, 
1990). This intron-binding surface on CYT-18 is distinct from that which 
binds tRNATyr, and was proposed to stabilize the P4-P6 and P3-P9 domains 
in the correct relative orientation (Paukstelis et al., 2008). The third group 
is non-specific RNA helicases, which function as ATP-dependent 
chaperone to destabilize non-native RNA structures that constitute kinetic 
traps in the folding pathway. Examples of the RNA helicases include CYT-
19 in N. crassa (Tijerina et al., 2006) and Mss116p in S. cerevisiae (Halls 
et al., 2007). 
Similar to CYT-18, LeuRS appears to facilitate splicing by 
recognizing features of the native structure (P6 stem-loop) in a magnesium-
inhibitory and ATP-independent manner (M. T. Boniecki et al., 2009). 
When LeuRS performs its aminoacylation activity in vitro, no Mg2+ 
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inhibition effect up to 10 mM Mg2+ was observed (Sarkar et al., 2012). 
Magnesium ion was proposed to be coordinated by amino acids in the 
aminoacylation catalytic center to help maintain the competent catalytic 
center conformation (Palencia et al., 2012). The Mg2+ inhibition effect in 
the splicing and annealing on the other hand indicates that bI4 intron 
splicing and P6n annealing stimulation are not performed by the 
aminoacylation catalytic center of LeuRS, or if it is, then the conformation 
of catalytic center to interact with the bI4 intron is different from the 
conformation to interact with tRNALeu. 
Different from CYT-18, which has distinct intron and tRNA binding 
surfaces, LeuRS employs the tRNA binding sites on the C-terminal domain 
to interact with the intron. It has been shown that the splicing-sensitive sites 
identified so far include not only tRNA binding site (Trp238) in the 
conserved “WIG” region of the editing domain connecting β-strands 
(Sarkar et al., 2012), but also the Gln273 and Leu277 residues in a less 
conserved region within the CP1 domain. Collectively, LeuRS uses both 
tRNA binding sites and splicing-specific inserts to promote group I intron 
splicing, which is different from CYT18 that has distinct tRNA and intron 
binding sites. 
We found that among LeuRSs ranging from prokaryotes to eukaryotes, 
LeuRS from yeast mitochondria has the highest activity in annealing the 
P6n duplex, which has the exactly same sequence as the P6 stem-loop, but 
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lacks advantage in annealing P6-33 duplex, which has the un-base-paired 
loops in the P6 stem designed to be base-paired, indicating that ymLeuRS 
is highly adapted in recognition of the P6 domain in the bI4 intron 
compared with other LeuRSs. Other than the P6n and P6-33 duplexes, 
LeuRS also supports annealing of a range of duplexes derived from the P6 
stem-loop. 
It is noteworthy that LeuRS didn’t support annealing of duplexes that 
are recognized by other published RNA annealing proteins (Muller et al., 
2001; Yang & Jankowsky, 2005), which supports the selectivity of the 
introns recognized by LeuRS, in contrast with CYT-18, which recognizes 
a variety of RNA sequences (Caprara, Lehnert, et al., 1996; Q. Guo & 
Lambowitz, 1992; G. Mohr, Caprara, Guo, & Lambowitz, 1994; G. Mohr 
et al., 1992). Also, LeuRS didn’t aid annealing of the P6 region in aI4α 
intron. The P6 stem-loop mimetic of the aI4α intron failed to anneal in the 
presence or absence of LeuRS (data not shown). This is not surprising 
because the P6 region of aI4α has only 15 base-pair, lower than the 
minimum base-pair number (18 base-pair) required in the annealing assay. 
This suggests that the aI4α intron does not require RNA remodeling in this 
area. 
Intriguingly, we observed a bias in LeuRS recognition of DNA-RNA 
hybrids: for the same P6-33 duplex sequence, LeuRS facilitates annealing 
of the 5’ DNA-3’ RNA version, but not the 5’ RNA-3’ DNA version. This 
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implicates other alternative functions of LeuRS, such as regulation of R-
loop formation (Thomas, White, & Davis, 1976), which is base-pairing of 
nascent RNA with its DNA template right after transcription, or mediation 
of non-coding RNAs interaction with their targets in the chromosome 
(Mercer, Dinger, & Mattick, 2009), and so on. 
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Chapter 6. Summary 
Aminoacyl-tRNA synthetases (AARSs) were originally discovered as 
a family of proteins that catalyze the first step of translation via a two-step 
aminoacylation reaction, which is addition of amino acids onto their 
cognate tRNAs (Ibba & Söll, 2000). Each amino acid is recognized by one 
AARS (Pang et al., 2014). AARSs can also prevent or edit tRNAs being 
mischarged with the wrong amino acid to ensure translational fidelity (A.P. 
Mascarenhas, Martinis, An, Rosen, & Musier-Forsyth, 2008). In addition 
to the primary functions of aminoacylation and editing, AARSs have been 
found to harbor a variety of secondary functions (Martinis et al., 1999), 
such as group I intron splicing function of mitochondrial LeuRS and TyrRS. 
My research focuses on unraveling mechanisms of LeuRS splicing 
function. 
The LeuRS in yeast mitochondria catalyzes splicing of the bI4 and aI4α 
introns in the genes encoding cytochrome b (cob) and the α subunit of 
cytochrome oxidase (cox1α) (Labouesse, 1990). Our lab has previously 
shown that the CP1 editing domain catalyzes intron splicing (Rho et al., 
2002; Sarkar, Mao, Lincecum, Alley, & Martinis, 2011), and characterized 
a splicing sensitive site Trp238 on one of the β-strands that connect the 
CP1 domain to the LeuRS main body (Sarkar et al., 2012). In my first 
project, in collaboration with Seung Bae Rho, we continued on to 
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characterize a splicing sensitive site on the CP1 domain, Gln273, and 
discovered another splicing sensitive site nearby, Leu277. We found that 
when either the Gln273 or the Leu277 site was mutated to alanine, the 
LeuRS mutant exhibited a significantly reduced processing of the bI4 
intron and formation of the exon, whereas the Q273R LeuRS mutant has 
similar intron splicing activity as the wild-type LeuRS. In the structural 
analysis, Gln273 and Leu277 were found to be located at the two ends of 
the β3 strand in the CP1 domain, Gln273 on the surface while Leu277 was 
buried. On the surface of ymLeuRS, several polar residues including 
positively charged amino acids were identified in proximity to the Gln273 
site, and proposed to comprise the intron face that interacts with the intron 
RNA. Interestingly, this intron face is distinct from the tRNA face where 
tRNA binding sites cluster on the CP1 domain, further supporting a 
previous hypothesis that the CP1 domain is diverged to accommodate both 
splicing and editing (Sarkar et al., 2011). 
Apart from LeuRS in yeast mitochondria, our group has discovered that 
LeuRSs in other organisms also harbor bI4 intron splicing activity, 
including LeuRS in E. coli,   M. tuberculosis and human mitochondria, 
although they never encounter the bI4 intron in the nature (Houman et al., 
2000; Poruri, 2007). In my second project, we characterized a splicing 
sensitive site Ala293 on the CP1 domain of EcLeuRS. The Ala293 residue 
is located in a relatively non-conserved region and was previously 
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identified as an aminoacylation and editing sensitive site (Williams & 
Martinis, 2006). We found that when expressed at a high level, A293D, 
A293K and A293R EcLeuRS mutants as well as wild-type EcLeuRS 
complemented a ymLeuRS-null yeast strain. In contrast, when expressed 
at a low level, WT and A293D EcLeuRS failed to complement the splicing 
function of ymLeuRS, whereas A293K and A293R EcLeuRS mutant still 
rescued growth of the ymLeuRS-null yeast strain. The in vitro splicing 
assays confirmed that A293D EcLeuRS indeed lacks splicing activity, and 
demonstrated that A293R has a compromised but still significant splicing 
activity, while A293K has similar activity as WT EcLeuRS. These results 
infer that other factors other than the splicing activity of the EcLeuRS 
mutants per se are responsible for their in vivo compensation of ymLeuRS 
splicing function. Combined with the lack of the A293 conserved site in 
ymLeuRS, it is likely that the non-native splicing-active LeuRSs from other 
organisms facilitate bI4 intron splicing in a completely different 
mechanism than ymLeuRS. 
In my third project, the mechanism of ymLeuRS-dependent splicing 
was further elucidated. Based on the preliminary RNA footprinting results 
that LeuRS interacts with the P6 stem-loop of the bI4 intron, it was 
hypothesized that LeuRS promotes annealing of the P6 stem so as to 
facilitate intron folding into a splicing competent conformation. To test that 
hypothesis, a series of RNA duplexes were designed based on the P6 stem-
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loop sequence and were shown to anneal much more rapidly in the 
presence of LeuRS in a magnesium-inhibitory and ATP-independent 
manner. The ymLeuRS enzyme was exhibited to possess the highest 
annealing activity and to recognize certain features of the P6 stem-loop, 
compared with LeuRSs from other organisms. By “dissecting” the LeuRS, 
we found the C-terminal domain is involved in the annealing activity of 
LeuRS. Furthermore, it was revealed that the cognate tRNALeu inhibited 
LeuRS-facilitated duplex annealing, indicating that the tRNALeu and the 
bI4 intron P6 stem share binding sites on LeuRS. In addition, a tRNALeu-
variable-arm-like region was identified on P6 stem and was shown to be 
important for LeuRS-dependent annealing. To further characterize the 
features on the P6 stem-loop that is recognized by LeuRS, we designed a 
variety of P6-derived duplexes and found that LeuRS only anneals 
duplexes longer than 18 bp and prefers duplexes with longer overhangs. 
LeuRS also demonstrated bias in DNA-RNA hybrid duplex annealing: it 
only promotes annealing of 5’ DNA-3’ RNA but not 5’ RNA-3’ DNA 
duplex. The bias in duplex recognition indicates other non-canonical 
functions that involve DNA-RNA hybrid annealing, such as transcription 
regulation. 
In summary, my studies further unveil the mechanism of LeuRS-
dependent annealing. We showed that although group I intron splicing 
function is universally present in LeuRSs ranging from prokaryotes to 
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eukaryotes, it seems that those non-native splicing LeuRSs facilitate 
splicing in a different mechanism than ymLeuRS. For example, splicing 
sensitive sites Ala293 in EcLeuRS and Arg399 in MtbLeuRS are conserved, 
but the corresponding conserved residue cannot be identified in ymLeuRS. 
Also, splicing sensitive site Gln273 in ymLeuRS lacks corresponding 
conserved residues in EcLeuRS and MtbLeuRS. In addition, we exhibited 
that one of the mechanisms LeuRSs employ to facilitate bI4 intron splicing 
is to promote annealing of the P6-stem. It was shown that ymLeuRS is 
highly adapted to recognize the P6 stem compared with LeuRSs from other 
organisms. Specifically, one of the key interacting region between 
ymLeuRS and the intron is the tRNALeu-variable-arm-like region on the P6 
stem, which ymLeuRS binds with its C-terminal domain. Combined with 
the discovery in the first project that LeuRS evolves new intron binding 
face on the CP1 domain, and the previous finding that Trp238 on the tRNA 
binding face of the CP1 domain is splicing sensitive (Sarkar et al., 2011), 
it seems that LeuRS not only uses tRNA binding sites, but also has 
developed novel intron binding sites to interact with and facilitate splicing 
of the group I introns. 
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Appendix. Plasmid constructs 
Plasmid name Parent vector Description 
p14ZL-ymLeuRS-Q273A p14MB-ymLeuRS-WT Gln273 mutated to Ala 
p14ZL-ymLeuRS-Q273R p14MB-ymLeuRS-WT Gln273 mutated to Arg 
p14ZL-ymLeuRS-L277A p14MB-ymLeuRS-WT Leu277 mutated to Ala 
pGP1-2-EctRNALeu-VL pGP1-2 Replace ymtRNALeu variable arm 
with EctRNALeu variable arm 
pGFIB-I-ymtRNALeu-VL pGFIB-I Replace EctRNALeu variable arm 
with ymtRNALeu variable arm 
 
